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ABSTRACT 
This dissertation examines the role of protein-protein interactions that regulate the 
conformation and function of the Tec family kinase, interleukin-2 tyrosine kinase (Itk). Tec 
family kinases are expressed in hematopoetic cells and modulate intracellular signaling 
cascades in response to external stimuli. The domain structure of Tec family members 
contains the conserved SH3, SH2, and catalytic domains common to many kinase families, 
yet they are distinguishable by the presence of a unique N-terminal sequence. The 
mechanism by which Itk is regulated is not well understood. Both nuclear magnetic 
resonance spectroscopy and functional assays were used to elucidate a novel regulatory 
mechanism for Itk in the work presented in this dissertation. These studies demonstrate that 
the Itk SH2 domain adopts two distinct conformations in solution that are in slow exchange. 
The observed conformational heterogeneity is due to proline cis/trans isomerization around a 
single prolyl imide bond, generating a cis proline-containing conformer and a trans proline-
containing conformer. Each conformer displays unique ligand binding properties. The trans 
conformer preferentially binds phosphotyrosine-containing ligands, whereas the cis 
conformer is required for a novel intermolecular interaction with the Itk SH3 domain. This 
SH3-SH2 self-association interaction is mediated by the conserved aromatic ligand binding 
pocket on the Itk SH3 domain and a newly defined surface on the Itk SH2 domain. 
Proline cis/trans isomerization is not only an important switch in regulating ligand 
binding, we also observe that the conformational^ heterogenous proline residue is required 
for recognition of Itk as a substrate for the peptidyl-prolyl isomerase, cyclophilin A. 
Cyclophilin A accelerates the interconversion between the cis and trans Itk SH2 domain 
conformera. Furthermore, both in vitro and in vivo cellular experiments reveal that 
cyclophilin A inhibits Itk kinase activity. This observation allows us to propose a 
mechanistic model for a completely new mode of kinase regulation and reveals a cellular role 
for cyclophilin A in T cell signaling. In sum, this dissertation provides molecular details 
about the structure of the Tec family kinase, Itk, and the functional implications of these 
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CHAPTER 1. GENERAL INTRODUCTION 
Literature Review 
Cellular signal transduction events are exceedingly dynamic, with countless regulatory 
pathways monitoring responses to external and internal stimuli. Protein phosphorylation and 
dephosphorylation, through the enzymatic activity of protein kinases and protein 
phosphatases respectively, can result in significant structural rearrangements that alter a 
protein's conformation, ultimately regulating its biochemical activity (I). Thus, protein 
phosphorylation acts as a molecular switch in controlling cellular signaling pathways. Several 
disease states, such as autoimmune disorders, cancer, and immunodeficiency disorders, are 
accompanied by defective intracellular signaling pathways. These defects often result from 
mutations in genes that encode for protein kinases. For example, chronic myelogenous 
leukemia results from the recombination of two genes, one of which encodes for a protein 
kinase, that produce a chimeric signaling molecule displaying uncontrolled tyrosine kinase 
activity (2, 3). The importance of protein phosphorylation in regulating cellular processes 
cannot be overstated. Upon completion of the human genome, approximately 3% of the 
genes are known to encode for protein kinases (4); however, the molecular mechanisms by 
which many of these enzymes are regulated are not well understood. 
Protein-tyrosine Kinases. Protein-tyrosine phosphorylation is a reversible 
modification that can regulate both the conformation and function of proteins by switching 
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them between active and inactive states. Therefore, protein tyrosine kinases (PTKs) are 
critical for the regulation of cellular processes. There are two families of protein-tyrosine 
kinases: the transmembrane receptor family and the cytosolic nonreceptor family (5, 6). 
Both kinase families are necessary for mediating cellular signaling pathways. Although 
receptor and nonreceptor PTKs differ significantly in their noncatalytic domain structure, the 
catalytic domain is highly conserved between both families. The catalytic domain consists of 
two lobes: a small N-terminal lobe that is required for ATP binding, and a larger C-terminal 
lobe that is primarily involved in catalysis (7, 8). A key aspect to the regulation of PTKs is 
the phosphorylation of residue(s) in the region between the two lobes of the kinase domain, 
known as the activation segment. Phosphorylation of the activation segment results in 
conformational changes in the nucleotide binding site and catalytic site that allow for the 
correct orientation of ATP and substrate that is required for catalysis. 
Src Family Nonreceptor Protein-tyrosine Kinases. Currently, the approximately 
30 known nonreceptor PTKs have been grouped into five distinct families based on their 
noncatalytic domain sequences (9). The largest family of nonreceptor PTKs is the Src 
family, named after the src oncogene of the Rous sarcoma virus (10). The Src family consists 
of 9 members: Src, Lck, Pgr, Fyn, Blk, Hck, Lyn, Yes, and Yrk (11). In addition to the 
catalytic domain, Src kinases contain a unique N-terminal region, two noncatalytic domains: 
Src homology 3 (SH3) and Src homology 2 (SH2), and a C-terminal tail. The attachment of 
myristate, a C,4 fatty acid, to the N-terminal region is required for membrane localization 
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(12). The SH3 and SH2 regulatory domains mediate protein-protein interactions through 
their well characterized ligand binding sites. SH3 domains are known to bind proline-rich 
sequences that contain the PXXP motif, whereas SH2 domains bind phosphotyrosine-
containing sequences (13, 14). 
The regulatory mechanisms of the Src family PTKs have been defined by biochemical 
assays and high-resolution crystal structures (15-17). Enzymatic activity and substrate 
binding is mediated by two intramolecular interactions involving the SH3 and SH2 domains. 
Phosphorylation of Tyr527 (c-Src) in the C-terminal tail by the c-Src kinase (Csk) generates a 
phosphotyrosine-containing ligand that binds intramolecularly to the Src SH2 domain. The 
SH3 domain interacts intramolecularly with the linker region between the SH2 domain and the 
N-terminal kinase lobe, which adopts a polyproline type II helix. The intramolecular 
interactions mediated by both the SH2 and SH3 domains are critical for maintaining an 
inactive kinase. The contacts mediated by the regulatory domains alter the conformation of 
the kinase active site, which results in stabilization of an inactive state by displacing helix aC 
in the N-terminal kinase lobe, subsequently reorienting important ion pairs in the catalytic 
site, and by positioning the activation segment to block access to the catalytic site. 
Displacement of either intramolecular interaction through SH3 or SH2 domain ligand binding 
interactions with target proteins or dephosphorylation of Tyr527 in the C-terminal tail will 
result in autophosphorylation in trans of Tyr416 (c-Src) in the activation segment. 
Phosphorylation of Tyr416 results in a conformational switch in the residues near the active 
site, causing a restructuring of the activation segment and the movement of helix aC toward 
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the active site, thus allowing for a regain of catalytic activity. Mutations that disrupt either 
the SH3 or SH2 intramolecular interaction result in a constitutively active kinase and lead to 
uncontrolled cell growth. 
Tec Family Nonreceptor Protein-tyrosine Kinases. The Tec family, which is 
comprised of five members, Tec, Btk, Itk, Rlk/Txk, and Bmx, is the second largest 
nonreceptor PTK family (18). Tec and Bmx are expressed in both hematopoetic and non-
hematopoetic cells. Btk, Itk, and Rlk/Txk are expressed only in hematopoetic cells, and are 
known to participate in lymphocyte signaling cascades. Only Btk and Tec are expressed 
within B cells; however, T cells primarily express Itk, Rlk/Txk, and Tec. To date, Btk is the 
only Tec family kinase to be associated with a disease. Mutations or deletions in the Btk 
gene result in a hereditary immunological disorder, X-linked agammaglobulinemia in humans 
(XLA) (19, 20). Individuals with XLA have a severely compromised immune system, 
characterized by a lack of mature circulating B cells, thereby emphasizing the importance of 
Btk in B cell development. 
The Tec kinase family shares considerable sequence similarity to the Src family of 
PTKs within the SH3, SH2 and kinase domains. However, the Tec family differs from the 
Src kinases in both the amino-terminal and carboxy-terminal regions. Tec kinases lack the 
amino-terminal myristolylation sequence and the regulatory tyrosine residue in the carboxy-
terminal tail. Tec family kinases, with the exception of Rlk/Txk, contain an extensive amino-
terminal region that includes a pleckstrin homology domain (PH) and a Tec homology domain 
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(TH). Rlk/Txk lacks both a PH and TH domain, yet has a unique amino-terminal region 
containing a palmitoylated cysteine-rich region (21). 
The Tec family kinases are the only nonreceptor PTKs to contain a PH domain. In 
contrast to the constitutive membrane association of Src PTK family, the Tec kinases are able 
to associate transiently with the plasma membrane through binding of phospholipids, 
including phosphatidylinositol (3,4,5)-triphosphate (PIP3), a product of phosphoinositide 3-
kinase (PI3K), to the PH domain (22, 23). All members of the Tec kinases are predominately 
located within the cytoplasm of resting cells. Activation of Tec kinases occurs in response to 
stimulation of various cell-surface receptors, such as antigen receptors, growth factor 
receptors, G-protein coupled receptors, cytokine receptors, and integrin adhesion receptors 
(18, 23-26). Cell-surface receptor stimulation results in Tec family kinase membrane 
association, which has been shown to be required for activation. Indeed, a gain-of-function 
mutation in the Btk PH domain (E41K) generates an increased binding affinity for 
phosphatidylinositol (l,3,4,5)-tetraphosphate compared to the wildtype protein, thus 
resulting in an increase in membrane association and up regulation (27). Mutations in the Btk 
PH domain that result in a decrease or inability to bind PI3K phopholipid products, e.g. 
R28C, have been implicated in the impaired B cell development observed in mice with murine 
X-linked immunodeficiency (xid), a milder form of XLA (27, 28). Therefore, Tec family 
kinase activation (excluding Rlk/Txk) is dependent upon PI3K activity. 
It remains unclear why membrane association results in increased Tec family kinase 
activity. It has been proposed that membrane association may recruit the Tec family kinases 
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to distinct membrane compartments where they can participate in macromoiecular complexes 
with signaling partners such as members of the Src family of PTKs. Tec family kinases 
contain the conserved tyrosine phosphorylation site in the activation segment within the 
kinase domain, and phosphorylation of this tyrosine residue by Src family kinases results in 
the activation of Tec family kinases upon membrane association (29-32). 
Membrane association may also increase the local concentration of Tec kinases, thus 
leading to increases in activity through homodimerization. Three different Btk PH domain 
mutants bound to phosphatidylinositol ( 1,3,4,5)-tetraphosphate were all observed to 
dimerize through the same interface (33). PH domain mediated dimerizaton may be required 
for Tec family kinase activation and interaction with target proteins. Although the Tec 
family kinases are thought to be activated by Src family kinases in vivo, Tec family kinases 
are able to directly phosphorylate the tyrosine residue in the activation segment in the 
absence of Src family PTKs (34). Autophosphorylation of this tyrosine residue in the 
activation segment may be facilitated through dimerization. The Tec family kinases also 
contain a tyrosine phosphorylation site within the SH3 domain. This site becomes 
autophosphorylated following phosphorylation of the tyrosine residue in the activation 
segment in the kinase domain, and leads to the subsequent activation of Tec family kinases 
(32, 34, 35). Although it remains to be determined if autophosphorylation of the SH3 
domain in a full-length Tec kinase occurs in cis or in trans, Btk was able to phosphorylate its 
own SH3 domain in trans (34). Thus, similar to receptor PTKs, dimerization as an activation 
mechanism may play a role in Tec family nonreceptor PTK signaling cascades. 
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Within the Tec family kinases, the TH domain is located adjacent to the membrane 
translocating PH domain (36). A highly conserved region in the amino-terminal portion of the 
TH domain, referred to as the Btk motif, contains a zinc-binding motif. Missense mutations 
involving a conserved cyteine pair necessary for Zn"2 coordination within the Btk motif have 
also been associated with XLA (37). Disruption of the zinc-binding motif is thought to alter 
the protein's stability and fold. In fact, the presence of the TH domain was essential for 
obtaining large quantities of recombinantly expressed soluble PH domain needed for 
crystallization (38). In the crystal structure, the Btk motif was shown to pack against the 
PH domain, forming an extended loop stabilized by the presence of a zinc ion. Therefore, 
mutations that disrupt Zn+2 coordination would not only affect the fold of the TH domain 
but of the PH domain as well. 
The C-terminal portion of the TH domain is characterized by the presence of a 
proline-rich region containing the PXXP consensus sequence known to bind SH3 domains. 
Rlk/Txk contains this proline-rich region despite lacking a conventional TH domain. The SH3 
domains of Src family kinases; Fyn, Lyn, and Hck, have been shown to directly bind the 
proline-rich region of Btk and Rlk/Txk in vitro (39,40). In addition, the proline-rich region of 
Tec was shown to mediate an interaction with Lyn both in vitro and in vivo (41). This 
interaction with Src PTKs may promote phosphorylation of the tyrosine residue in the 
activation segment of the Tec and therefore result in Tec kinase activation. 
Btk and Tec contain two PXXP motifs within the proline-rich, amino-terminal 
portion of the TH domain. The N-terminal PXXP motif in both Btk and Tec binds 
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intramolecularly to its adjacent SH3 domain (42, 43). Whereas, the C-terminal PXXP motif 
participates in a higher affinity intermolecular SH3 domain binding interaction, resulting in 
homodimerization (42-44). Itk and Rlk/Txk contain one PXXP motif within the TH domain. 
The Itk PXXP motif is homologous to the N-terminal PXXP motif in Btk and Tec, and 
likewise binds intramolecularly to its adjacent SH3 domain (45). This Itk proline-SH3 
domain intramolecular interaction has been proposed to regulate the accessibility of the SH3 
ligand binding site in order to maintain an inactive/closed kinase. The PXXP motif in Rlk/Txk 
appears to be homologous to the C-terminal PXXP motif in Btk and Tec, thus one would 
predict that the Rlk/Txk PXXP motif would bind intermolecularly to a SH3 domain in a 
neighboring Rlk/Txk molecule. Perhaps both intramolecular and intermolecular proline-SH3 
domain interactions are necessary for regulating Tec family kinase activity. Similar to the 
intramolecular regulatory interaction between the Src SH3 domain and the kinase linker, the 
intramolecular proline-SH3 domain interactions observed for Tec, Btk, and Itk may prevent 
homodimerization and/or binding of other SH3 domain containing proteins that may lead to 
activation. Although the intermolecular proline-SH3 domain interaction in Btk or Tec would 
also prevent interactions with other proteins, this interaction would promote 
homodimerization, in which the activation state remains unknown. 
Autophosphorylation of the tyrosine residue in the SH3 domain (Y223 in Btk) would 
likely disrupt either the intermolecular or intramolecular proline-SH3 domain interaction. 
Inspection of the Itk, Btk, and Tec SH3 domain solution structures reveals that Y223 is 
located within the conserved aromatic ligand binding pocket (42, 45, 46). Y223 
9  
autophosphorylation appears to alter the ligand binding properties of the Btk SH3 domain 
(34). Phosphorylation of the Btk SH3 domain abolishes an interaction with the proline-rich 
region of the Wiskott-Aldrich syndrome protein (WASP), yet generates a proline 
independent high affinity interaction with the carboxy-terminal region of the spleen tyrosine 
kinase (Syk). In additon to the generation of novel SH3 domain ligand binding capacities, 
autophosphorylation may be a means of disengaging regulatory interactions mediated by the 
SH3 domain. The SH3 domain appears to affect the function of the Tec kinases through 
binding interactions with other proteins. For example, Itk becomes highly phosphoryated in 
response to SH3 domain binding to a proline-rich peptide originating from the costimulatory 
T cell receptor, CD28 (47-50). As well, mutation of Y223 or deletion of the SH3 domain in 
the upregulated Btk E41K mutant increased the transforming potential of Btk without 
affecting the kinase activity (31 ). Thus, the SH3 domain appears to play a regulatory role in 
modulating Tec family kinase function through protein-protein interactions analogous to the 
role of the SH3 domain in the Src PTK family. 
The SH2 domain, located adjacent to the SH3 domain, may also be involved in 
regulating the function of Tec family kinases. Based on molecular models and ligand binding 
assays, the SH2 domains of the Tec family kinases appear to bind phosphotyrosine-
containing sequences and adopt the characteristic SH2 domain fold, consisting of a central |3-
sheet flanked by two a-helices (51-54). The SH2 domains within the Tec family kinases 
have been shown to be required for interactions with adaptor proteins at the membrane. 
These SH2 mediated interactions may localize the Tec family kinases to a specific membrane 
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environment for participation in macromoiecular complexes, which provide the scaffold 
required for phosphorylation and subsequent kinase activation. It has been observed that the 
level of Itk phosphorylation upon anti-CD3 receptor stimulation in Jurkat T cells is 
unaffected by the expression of a kinase-dead Itk mutant (K390R) or deletion of the Itk SH3 
domain. In contrast, Itk fails to become highly phosphorylated when the Itk SH2 domain has 
been deleted or when the phosphotyrosine binding pocket has been mutated (55). The SH2 
domain phosphotyrosine pocket mutation in Itk is thought to disrupt a phosphotyrosine-
dependent interaction with the adaptor protein linker of activated T cells (LAT), and 
correlates with an absence of Itk phosphorylation and activation. The Btk SH2 domain also 
seems to be important for regulating function. Based on a model of the Btk SH2 domain, a 
series of mutants have been identified in XLA patients that are proposed to be located in the 
phosphotyrosine binding pocket (53, 54). Subsequent analysis of the Btk SH2 domain 
mutants using circular dichroism and surface plasmon resonance showed that the mutations 
decrease the binding affinity for phosphotyrosine-containing ligands. Several of these 
mutations affected the overall fold and stability of the SH2 domain. Therefore, the SH2 
domain may be necessary for participation in intermolecular interactions necessary for 
localization of the Tec family kinases and activation. 
As stated previously, contacts required for maintaining an inactive Src kinase are due 
to the formation of an intramolecular interaction between the SH3 domain and the linker 
region between the SH2 domain and the kinase domain. Unlike the Src family of PTKs, a 
direct interaction between the regulatory domains and the catalytic domain of the Tec kinases 
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does not appear to be neceassry in order to maintain an inactive state prior to 
phosphorylation of the the tyrosine residue in the activation segment. A crystal structure of 
the unphosphorylated/inaclive form of the Btk kinase domain has been completed (56). The 
Btk kinase domain is proposed to maintain an inactive conformation through interactions 
between residues in helix aC in the N-terminal kinase lobe and residues in the activation 
segment, e.g. hydrogen-bonded pair Glu-445/Arg-544. Such interactions prevent the 
formation of a critical interaction between Glu-445 and Lys-430 in the active site, which 
would reorient helix aC and residues in the activation segment, allowing for a regain of 
catalytic activity. Phosphorylation of the tyrosine residue (Tyr-551) in the activation 
segment is proposed to alleviate interactions that maintain the inactive conformation of the 
catalytic site. Phosphorylation of Tyr-551 may result in an interaction between Arg-544 and 
the phosphate group of pTyr-551, thereby allowing Glu-445 to be in a postion to interact 
with Lys-430. Formation of the Glu-445/Lys-430 interaction would re-position helix aC and 
the activation segment, hence activating the catalytic site. 
Activation of the kinase domain leads to autophosphorylation of the tyrosine residue 
in the SH3 domain, the second requirement for a fully active Tec family kinase. To date, little 
is known about physiological Tec family kinase substrates once activated. Analogous to 
many non-receptor PTKs, the Tec kinases appear to phosphorylate tyrosine-containing 
sequences that are ligands for their own SH2 domains or closely related SH2 domains (57). 
For example, Tec specifically phosphorylates a tyrosine residue in Dok-1. In turn, 
phosphorylated Dok-1 binds to the Tec SH2 domain, and this association results in 
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hyperphosphorylation of Dok-1 (58, 59). Likewise, Rlk/Txk has been shown to 
phosphorylate the tyrosine-containing sequence YEPP in the 76kD SH2-domain-containing 
leukocyte protein (Slp-76), following which, this phosphotyrosine-containing sequence of 
Slp-76 acts as a ligand for the Itk SH2 domain (52, 60). 
The presence of four different regulatory domains, e.g. PH, TH, SH3, and SH2, enable 
the Tec family kinases to participate in a multitude of protein-protein interactions. These 
protein-protein interactions are important for controlling Tec family kinase activity, and are 
required for their role in mediating cellular signaling pathways. The Tec family kinases 
participate in a varitey of signaling pathways emanating from a number of different cell 
surface receptors. The T cell specific Tec family member, Itk, is essential for mediating 
signaling events necessary for T cell activation in response to antigen receptor stimulation 
T cell Activation. One aspect of the immune system required for the elimination of 
foreign pathogens is T cell activation. An antigen-presenting cell (APC), displaying a major 
histocompatibility complex (MHC) bound to a foreign peptide on its surface, is able to 
attract and bind to a circulating T cell through its T cell receptor (TCR), thereby initiating T 
cell activation. Once the TCR-APC interaction occurs, TCR signaling follows within seconds, 
resulting in protein clustering and rapid increases in intracellular protein phosphorylation 
levels (61-63). In addition to the TCR, other molecules on the surface of the T cell 
participate in activation by functioning as co-receptors. Co-receptors are able to increase the 
affinity of the interaction with either the antigen or the APC, or activate separate signal 
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transduction events that affect the cellular response. Signaling events during T cell activation 
result in the secretion of cytokines that regulate the intensity and duration of the T cell 
immune response. The cytokine interleukin-2 (IL-2) is an autocrine growth factor produced 
only upon T cell activation, primarily by T cells expressing the surface antigen CD4 (64). 
Biological activities of IL-2, such as regulation of T cell proliferation and progression through 
the cell cycle, are mediated by the IL-2 membrane receptor that is expressed almost 
exclusively on the surface of activated T cells (65, 66). Protein phosphorylation and more 
specifically protein-tyrosine phosphorylation is critical for the initiation of cellular responses 
that lead to both the production of IL-2 and the IL-2 receptor. 
The TCR lacks intrinsic tyrosine kinase activity; however, the T cell co-receptor CD4 
contains a cytoplasmic domain that associates with the Src family nonreceptor PTK 
lymphoid cell kinase (Lck) following T cell activation (67, 68). Upon association with CD4, 
Lck mediates post-receptor signal transduction events by phosphorylating the TCR 
cytoplasmic domain sequences termed immunoreceptor tyrosine-based activation motifs 
(ITAM) (69, 70). ITAMs are approximately 15 residue sequences that contain two tyrosine 
residues with the consensus sequence YxxL (x) 6.8YxxL. Tyrosine phosphorylation of 
ITAMs initiates an activation cascade dependent upon PTK activity. In fact, inhibitors of 
PTK activity are able to disrupt both early and late events during T cell activation, such as 
increases in intracellular calcium levels, cytokine secretion, and T cell proliferation (71). 
Therefore, PTKs play a critical role in T cell activation, where nonreceptor PTKs are 
14  
essential for translating receptor signaling events in the T cell that ultimately lead to the 
expression of IL-2. 
The Role of the Tec Family Kinase Itk in T cell Activation. The T cell specific 
Tec family kinase, interleukin-2 tyrosine kinase (Itk), is critical for mediating antigen-receptor 
signaling pathways, and is therefore required for T cell activation (72, 73). The importance of 
Itk in antigen-receptor signaling pathways has emerged through experiments on mice lacking 
Itk (74-78). Itk deficient mice display several defects, among which include reduced IL-2 
production and impaired proliferative responses following T cell receptor stimulation. 
Early T cell receptor events are unaffected by the lack of Itk, however; intermediate 
events are impaired that result in reduced IL-2 production and subsequently affect T cell 
proliferation. Immediately upon T cell receptor stimulation, Lck phosphorylates the T cell 
receptor IT AM motifs and Itk. Phosphorylation of ITAMs recruits the 70kD zeta chain 
associated protein (Zap-70) to the T cell receptor zeta chain, which leads to Zap-70 
phosphorylation and activation. In turn, Zap-70 then phosphorylates LAT, and then Itk 
associates with phosphorylated LAT through the SH2 domain and Itk is then able to 
phosphorylate phospholipase Cyl (PLC yl) (70, 79, 80). T cell receptor phosphorylation 
and Zap-70 levels of phosphorylation remain unaffected by the lack of Itk (75). However, 
the level of (PLC y I) phosphorylation, and consequently activation, is decreased in Itk 
knockout mice, consistent with the observation that the level of PLC yl phosphorylation 
parallels the level of Itk phosphorylation. Activated PLC yl hydrolyzes membrane bound 
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phosphatidylinositol (4,5)-bisphosphate (PIP2) to produce diacylglycerol (DAG) and 
inositol (3,4,5)-trisphosphate (IP3) (81). IP3 then binds to IP3-gated channels on the 
endoplasmic reticulum (ER) and releases calcium stores from the lumen of the ER. Emptying 
of these stores causes the plasma membrane calcium channels to open, resulting in a sustained 
calcium flux that leads to the translocation of the transcription factor nuclear factor of 
activated T cells (NFAT). Once in the nucleus, NFAT binds to the IL-2 promotor region and 
activates transcription. Consistent with the role of Itk activating PLC yl, a decrease in 
calcium elevation and NFAT translocation is observed after T cell receptor stimulation in Itk 
deficient mice, and correlates with a decrease in IL-2 promoter activity (76, 82). Thus, Itk 
appears to be necessary to generate fully phosphorylated and activated PLC yl, following 
which IL-2 is produced and T cell proliferation is intiated upon binding of IL-2 to the IL-2 
receptor. 
The distinct roles of Itk in regulating T cell activation and other cellular processes are 
only beginning to emerge. The signaling complexes that Itk participates in, and its mechanism 
of regulation are not well understood. As one would expect, based on the number of different 
regulatory domains and the multitude of interactions with various signaling molecules, Itk 
appears to integrate numerous pathways emanating from a variety of cell-surface receptors. 
Continued use of genetic, biochemical and structural approaches will significantly advance our 
understanding of Itk, thus clearly defining its function in mediating important cellular 
processes of the immune system. 
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Dissertation Organization 
Chapter 1 of this dissertation contains a review of the literature. Chapters 2 and 3 
have been published in peer-reviewed journals. Chapter 4 has been submitted for publication, 
and has therefore been formatted according to the preferences of the journal. As first author, 
I performed all of the experiments described in Chapters 2-4, with the exception of figure 2 in 
Chapter 3, in which Dr. Robert J. Mallis calculated the SH2 domain surface structures. In 
addtion, Chapters 2-4 benefited greatly from discussions with Dr. Amy H. Andreotti, Dr. D. 
Bruce Fulton, and Dr. Robert J. Mallis. Chapter 5 provides a general summary and 
conclusions of Chapters 2-4. 
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CHAPTER 2. A Specific Intermolecular Association Between the 
Regulatory Domains of a Tec Family Kinase 
A paper published in the Journal of Molecular Biology (2000) 302, 607-623 
Kristine N. Brazin, D. Bruce Fulton and Amy H. Andreotti 
Summary 
Interleukin-2 tyrosine kinase, Itk, is a T-cell specific tyrosine kinase of the Tec 
family. We have examined a novel intermolecular interaction between the SH3 and SH2 
domains of Itk. In addition to the interaction between the isolated domains, we have found 
that the dual SH3/SH2 domain-containing fragment of Itk self-associates in a specific manner 
in solution. Tec family members contain the SH3, SH2 and catalytic domains common to 
many kinase families yet are distinguished by a unique amino-terminal sequence, which 
contains a proline-rich stretch. Previous work has identified an intramolecular regulatory 
association between the proline-rich region and the adjacent SH3 domain of Itk. The 
intermolecular interaction between the SH3 and SH2 domains of Itk that we now describe 
provides a possible mechanism for displacement of this intramolecular regulatory sequence, a 
step that may be required for full Tec kinase activation. Additionally, localization of the 
interacting surfaces on both the SH3 and SH2 domains by chemical shift mapping has 
provided information about the molecular details of this recognition event. The interaction 
involves the conserved aromatic binding pocket of the SH3 domain and a newly defined 
binding surface on the SH2 domain. The interacting residues on the SH2 domain do not 
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conform to the consensus motif for an SH3 proline-rich ligand. Interestingly, we note a 
striking correlation between the SH2 residues that mediate this interaction and those residues 
that, when mutated in the Tec family member Btk, cause the hereditary immune disorder, X-
linked aggamaglobulinemia (XLA). 
Introduction 
The Tec family non-receptor tyrosine kinases (Tec, Btk, Itk, Bmx and Rlk) 
participate in intracellular signaling events that are initiated by stimulation of surface 
receptors on hematopoetic cells (Bolen, 1995; reviewed by Mano, 1999). Bruton's tyrosine 
kinase, Btk (Vetrie et al., 1993; Tsukada et al., 1993) and Interleukin-2 tyrosine kinase, Itk 
(Heyeck & Berg, 1993; Yamada et ai, 1993; Siliciano et ai, 1992) are important members of 
the B cell and T cell receptor signaling pathways, respectively. Mutations in the Btk gene 
cause the severe hereditary immunological disorders, X-linked agammaglobulinemia (XLA) in 
humans and X chromosome-linked immunodeficiency (Xid) in mice (Vetrie et al., 1993; 
Tsukada et ai, 1993; Rawlings et ai, 1993; Thomas et ai, 1993). The link between 
alterations in the Btk sequence and the occurrence of these diseases emphasizes the 
importance of this family of protein kinases in achieving a proper immune response. The 
details of the signaling pathways that the Tec kinases participate in and the mechanism by 
which these kinases are regulated are not well understood. In contrast, the regulatory 
mechanism of the structurally related Src kinases has recently been clearly defined by high 
resolution crystal structures of two family members (Xu et al. 1997; Sicheri et al. 1997). 
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Substrate binding and enzymatic activity of the Snc kinases are controlled by intramolecular 
interactions mediated by both the Src homology 2 (SH2) and Src homology 3 (SH3) domains 
(Courtneidge, 1985; Cooper, 1993; Hunter, 1987). 
The Src and Tec kinase families share sequence homology in the SH3, SH2 and the 
catalytic tyrosine kinase domains yet display distinguishing characteristics in the carboxy-
and amino-terminal regions. The C-terminal regulatory phosphorylation site in the Src 
kinases is absent in the Tec kinases; however, the Tec kinases contain an extensive amino 
terminal region made up of a Pleckstrin homology (PH) domain (Lemmon et al., 1996) and a 
Tec homology (TH) domain (Vihinen, 1994) not present in the Src kinases. The unique 
amino terminal TH domain of the Tec family members contains a proline rich sequence that 
participates in an intramolecular interaction with the downstream SH3 domain in Itk 
(Andreotti et al., 1997). Formation of the intramolecular SH3-proline complex within Itk 
regulates binding of other protein ligands and may therefore be implicated in controlling the 
activity of Tec family kinases (Andreotti, 1997). 
Exogenous ligands have been identified that associate with the SH3 domain of Src 
kinases leading to displacement of the intramolecular SH3 and SH2 ligands and ultimately Src 
kinase activation (Moarefi, 1997). While the mechanism of Tec kinase activation is not as 
well understood, ligands have been identified that may potentiate kinase activity by binding 
to the non-catalytic domains of Tec (Bence et al., 1997; Bunnell et al., 1996; Bunnell et al., 
2000). There is mounting evidence that Itk activation is mediated in part by association with 
the signaling scaffold protein, Lat, which may serve to co-localize Itk with its activation 
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partners (Shan & Wange, 1999). It has been proposed that multivalent interactions between 
Itk and other co-localized signaling proteins may serve to disrupt the intramolecular proline-
SH3 interaction leading to concomitant activation steps (Andreotti et al., 1997; Su et al., 
1999; Schneider et al., 2000; Bunnell et al., 2000). Another line of evidence supporting the 
notion that displacement of the intramolecular SH3-mediated interaction is required for full 
Tec kinase activity is that autophosphorylation on a tyrosine residue in the SH3 ligand-
binding pocket of Btk correlates with Btk kinase activation (Park et al., 1996; Nisitani, 1999; 
Wahl, 1997). This phosphorylation event would most likely require prior removal of the 
intramolecular proline ligand from the SH3 binding pocket. We have now identified a novel 
interaction involving the SH3 and SH2 domains of Itk that may, in the proper cellular context, 
play a role in Itk activation by displacing the putative regulatory proline sequence from the 
SH3 binding pocket. 
The structures and binding specificities of the two ubiquitous adaptor modules, SH2 
and SH3, have been extensively investigated and are well understood (reviewed by Kuriyan & 
Cowbum, 1997). SH2 domains consist of a central p-pleated sheet flanked by two a-helices 
and bind to phosphotyrosine(pTyr)-containing sequences (for a secondary structure map of 
the SH2 domain see Figure 4). Phosphopeptide binding is mediated through a 'two-prong' 
mechanism that involves two well-defined pockets on the surface of the SH2 domain. The 
phosphotyrosine binding pocket of the SH2 domain consists of three conserved basic 
residues that interact with the phosphotyrosine sidechain through hydrogen bonds, 
hydrophobic and electrostatic contacts. In addition, a more variable specificity pocket on the 
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SH2 domain binds residues C-terminal to the pTyr. SH3 domains are made up of two 
perpendicular antiparallel P-sheets and are very often found adjacent to SH2 domains in 
signaling proteins. The SH3 adaptor module recognizes proline-rich sites that adopt a left-
handed polyproline type II (PPII) helix conformation. The ligand binding site on the SH3 
domain is comprised of conserved aromatic residues. Additionally, there are two variable 
regions, named the RT and n-src loops, that participate in ligand binding. To date, almost all 
SH3 ligands identified are short contiguous sequences that contain a PXXP consensus motif 
(Chen et al., 1993). Most SH3 domains contain an acidic residue in the RT loop that forms a 
critical electrostatic interaction with a basic residue (arginine or lysine) adjacent to the PXXP 
motif in the ligand. Formation of this salt bridge determines the binding orientation of the 
polyproline peptide; two opposite binding orientations have been characterized (Feng et al., 
1994). 
There are notable exceptions to these well-characterized SH2 and SH3 consensus 
ligands. Phosphotyrosine-independent SH2 mediated interactions have been observed 
previously. The SH2 domain of SAP, the product of the mutated gene in human X-linked 
lymphoproliferative (XLP) disease, interacts with phosphorylated tyrosine-containing 
peptides as well as the corresponding non-phosphorylated sequences (Li et al., 1999). This 
unusual recognition is achieved through contacts to the residues surrounding the Tyr residue 
in both the amino and carboxy direction (Poy et al., 1999). As another example of atypical 
SH2 recognition, several SH2 domains have been shown to bind to phosphorylated serine or 
threonine containing motifs that lack a phosphorylated tyrosine residue (Cleghon & 
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Morrison, 1994; Dutartre et al., 1998; Malek & Desiderio, 1994; Nantel et al., 1998; 
Pendergast et al., 1991). Additionally, there are SH2 mediated interactions that do not rely at 
all on the presence of a phosphorylated residue in the recognition motif. The She binding 
protein PAL (Protein expressed in Activated Lymphocytes) interacts specifically with the 
She SH2 domain and yet is not phosphorylated (Schmandt et al. 1999). As well, the 
interaction between the Lck SH2 domain and the 62-kDa cytosolic protein, p62, does not 
require phosphorylation of tyrosine, serine or threonine and is unaffected by mutation of the 
invariant arginine in the Lck SH2 domain (Joung et al., 1996). It has been proposed that this 
interaction may make use of a distinct ligand binding surface on the SH2 domain. 
SH3 domains are also capable of unconventional ligand recognition. An entirely 
proline-independent interaction has been characterized between the SH3 domain of the 
immune cell adaptor, SKAP55 and the novel peptide motif, RKXXYXXY (Kang et al., 
2000). This tyrosine-based motif appears to contact the SH3 domain surface in a manner 
that is similar, but not identical, to the proline-rich sequences previously studied. Another 
example of unusual SH3 binding selectivity has been demonstrated for Eps8, an SH3-
containing substrate for receptor and non-receptor tyrosine kinases that has been implicated 
in mitogenic signaling (Fazioli et al., 1993; Gallo et al., 1997; Wong et al., 1994). 
Identification of physiological ligands for Eps8 as well as screening of phage display peptide 
libraries has revealed a marked preference for a PXXDY sequence (Mongiovi et al., 1999). 
The DY portion of this sequence is absolutely required for binding and the proline residue 
appears to be a specificity determining element. To date, the three-dimensional structures of 
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the SKAP55 and Eps8 SH3 domains bound to their respective non-PXXP containing ligands 
are not available to facilitate a comparison of the different modes of ligand recognition. 
Additionally, the aforementioned intramolecular SH3 ligand within the Src tyrosine kinase 
does not conform to the signature PXXP motif (Xu et al. 1997). The sequence, 
KPQTQGLA, contains a single proline residue and yet adopts the left-handed PPII helical 
conformation when bound in an intramolecular fashion to the SH3 domain of Src. The 
unconventional substrate selectivity exhibited by these SH2 and SH3 domains suggests that 
the molecular recognition events mediated by these small adaptor domains may be more 
diverse than previously believed. 
SH2 domains themselves have been implicated as SH3 binding partners. The Crk-II 
SH2 domain contains a proline-rich insert in the DE loop that interacts with a subset of SH3 
domains (Anafi et al., 1996). This insert is not required for binding of the Crk-II SH2 domain 
to pTyr-containing sequences. However, pTyr ligand binding to the Crk-II SH2 domain does 
appear to enhance the interaction of the SH2 proline-rich insert with SH3 domains. Two 
other examples of SH3-SH2 interactions have been reported. Biochemical investigations have 
revealed intermolecular interactions between the SH2 and SH3 domains of the Src kinase 
family (Panchamoorthy et al., 1994). These interactions appear to be specific since the Src 
family SH3 domains do not bind to the SH2 domains of non-Src family kinases such as Abl 
and PI3-K or to SH2 domains of the noncatalytic proteins Grb-2 and Crk. Additionally, the 
crystal structure of an SH2 and SH3 dual domain-containing fragment of Lck revealed a head-
to-tail dimer where the SH3 domain of one monomer directly contacts the SH2 domain of the 
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neighboring monomer (Eck et al., 1994). While this structure provides molecular details for 
the SH3-SH2 interaction which are lacking in the previously mentioned studies, the complex 
was not observed in solution and therefore questions can be raised as to the role of fortuitous 
crystal packing in stabilizing the interaction. 
We have now characterized an /ntormolecular interaction in solution between the SH3 
and SH2 domains of Itk. The interaction occurs between the singly expressed SH2 and SH3 
domains of Itk as well as between two SH3/SH2 dual domain-containing fragments (Itk 
SH32). Using nuclear magnetic resonance (NMR) spectroscopy we have mapped out the 
residues of each domain involved in complex formation. The Itk SH3 binding pocket interacts 
in an intermolecular fashion with four loops (AB, CD, EF and BG, see figures 3&4) of the 
SH2 domain. In contrast to the Crk-II SH2 domain (Anafi et al., 1996), the loops in the Itk 
SH2 domain do not contain a primary sequence that resembles the PXXP consensus motif for 
SH3 recognition. We have examined the ability of the Itk SH3 and SH2 domains to interact 
with the respective domains of non-Tec family kinases and have not detected binding. A 
comparison of the sequence homology between a representative group of SH2 domains 
provides a possible explanation for this observed specificity. Finally, we propose a 
functional relevance for this interaction in regulating Tec kinase activity. 
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Results and Discussion 
Self-association of the Itk SH32 dual domain fragment 
To investigate the possibility of self-association between the regulatory domains of 
Itk, a dual SH3 and SH2 domain-containing fragment of Itk (SH32) as well as the isolated Itk 
SH3 and SH2 domains were bacterially expressed and purified. 'H-15N heteronuclear single 
quantum correlation (HSQC) spectra of recombinant Itk SH32, Itk SH3 and Itk SH2 are 
shown in Figure 1 A, C & D. Chemical shift dispersion of the crosspeaks typical of folded 
protein is observed for each fragment of Itk, facilitating sequence specific resonance 
assignments. The crosspeaks in the single domain spectra (Fig. 1 C&D) are not exact subsets 
of the dual domain-containing fragment, Itk SH32. In addition to the overall line broadening 
observed, chemical shift perturbations as well as disappearance of some crosspeaks are 
observed for Itk SH32 as compared to the isolated domains. These spectral changes are either 
due to the covalent linkage between the two domains and/or arise from an interaction between 
domains. To test the possibility that the dual domain-containing fragment (Itk SH32) self-
associates, a mutant of the Itk SH32 dual domain was constructed (Itk SH3*2(W208K)) in 
which Trp 208 (a critical residue in the SH3 binding pocket) was changed to a Lys. 
Comparison of the HSQC spectra for the single domains (Fig. 1 C&D) with the 
corresponding resonances of the Itk SH3*2(W208K) mutant (Fig. IB) reveals only small 
chemical shift differences due to the mutated residue and similar linewidths. The observed line 
broadening taken together with changes in the resonance frequencies of a subset of residues 
suggests that Itk SH32 self-associates in a manner that requires an intact SH3 binding pocket. 
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Association of the single domains and localization of the binding interface 
To simplify analysis of the residues that mediate the self-association of the Itk SH32 
fragment in solution, we investigated the potential interaction of the isolated SH3 and SH2 
domains. Titration of unlabeled Itk SH2 into an NMR sample of l5N-ltk SH3 results in 
significant perturbation of the chemical shift and/or change in linewidths of 30 of the 65 
backbone 'H/I5N crosspeaks in the HSQC spectrum (Fig. 2A). Likewise, the reverse titration 
of unlabeled Itk SH3 into l5N-Itk SH2 causes changes in 33 of 104 backbone 'H/I5N 
crosspeaks in the HSQC spectrum (Fig. 2B). The observed shifts in both the SH3 and SH2 
domains in these titration experiments correspond closely to the chemical shift perturbations 
observed in comparing Itk SH32 with the Itk SH3*2(W208K) mutant (Fig. 1A&B, Fig. 2). 
Thus, the contacts that mediate self-association between dual domain containing fragments of 
Itk also occur between the Itk SH3 and SH2 domains when expressed as separate fragments. 
The intermolecular association of the Itk SH3 and SH2 domains in solution has enabled us to 
use chemical shift mapping to investigate this interaction on a residue specific basis. 
Complete sequence specific backbone resonance assignments for recombinant l5N/l3C 
doubly labeled Itk SH2 and SH3 domains have been carried out using standard triple 
resonance experiments. Identification of residues that shift upon addition of unlabeled Itk 
SH2 domain to 15N labeled Itk SH3 (Fig. 2A) reveal that the surface on the Itk SH3 domain 
involved in the interaction encompasses the well characterized ligand binding pocket formed 
by conserved aromatic residues. This is consistent with the observation that mutation of the 
conserved tryptophan (W208) in the SH3 binding pocket of the dual domain-containing 
fragment abrogates self-association (Fig. IB). Chemical shift perturbations in the labeled SH2 
domain induced upon addition of unlabeled SH3 domain were used to map out the region of 
the SH2 domain involved in this interaction (Fig. 2B). The corresponding residues localize 
the Itk SH2 domain binding surface to four loops: AB, CD, EF and BG. These loops form a 
contiguous surface on the tertiary structure of other SH2 domains for which structures have 
been solved. The residues on the Itk SH2 domain involved in the interaction do not contain 
the conventional PXXP motif known to bind SH3 domains nor the PXXDY motif previously 
described as a binding site for the Eps8 SH3 domain. Thus, the Itk SH3-SH2 interaction has 
revealed a novel binding capacity of the Itk SH3 domain. 
The fact that the Itk SH2 domain contacts the conserved ligand binding site of the 
SH3 domain suggests that the intermolecular SH3-SH2 interaction may play a role in 
regulating the intramolecular Itk proline-SH3 association described previously (Andreotti et 
al., 1997). The juxtaposition and resulting intramolecular interaction of the proline-rich 
sequence and the SH3 receptor within Itk has been shown to limit the binding of other ligands 
to the SH3 binding pocket (Andreotti et al., 1997). However, titration of unlabeled Itk Pro-
SH3 into a sample containing 15N-Itk SH2 reveals chemical shift perturbations within the 
SH2 domain that are identical to those observed in the direct SH3-SH2 interaction (see Figure 
2B). This result suggests that the intramolecular regulatory complex of Itk may be disrupted 
by intermolecular interactions between Itk molecules. 
In the absence of a high-resolution structure of the Itk SH32 dual domain, we have 
used the previously determined structure of the Lck SH32 dual domain fragment (Eck et al., 
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1994) to examine the nature of the binding surfaces mapped out for Itk by NMR. A surface 
map of the Lck SH32 dual domain fragment highlighting the residues that mediate the Itk 
SH3-SH2 interaction is shown in Fig. 3A. The chemical shift perturbations of the SH3 
domain are localized to the conserved aromatic binding pocket along with residues that make 
up the more variable RT and n-Src loops. Unlike the SH3 domain, the chemical shift 
perturbations of the SH2 domain do not map out a previously characterized binding surface. 
The interaction between the Itk SH2 and SH3 domains involves four loop regions (AB, CD, 
EF, and BG) that link the regular secondary structural elements of the SH2 domain. The 
binding surface includes part of the well defined pTyr peptide binding site; the EF and BG 
loops form the ridges of the pY+3 pocket and contribute sidechains that determine the 
specificity of pTyr peptide binding. The binding interface extends to include the AB and CD 
loops forming a ridge along one face of the SH2 domain. There are a number of basic residues 
present in each of the four loop regions of Itk (see Figure 4) that may form critical 
electrostatic interactions with acidic residues present in the binding pocket of the Itk SH3 
domain. For both the SH3 and SH2 domains, the chemical shift perturbations map out a 
relatively large region on the surface of the protein. This surface may be larger than the direct 
contact area of interaction because residues with binding-induced chemical shift perturbations 
generally define a region beyond the area involved in the direct protein-protein interaction 
(Spitzfaden et al., 1992). 
A comparison of the interaction surfaces in the dual SH32 domains of Itk and Lck 
(Eck et al„ 1994) reveals that both complexes exploit the conserved aromatic binding pocket 
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of the SH3 domain (Fig. 3B). In contrast, the SH2 residues involved in the Itk SH32 self-
association are quite different from those that mediate Lck dimer formation. A small region 
on the EF loop of the SH2 domain is common to the interaction surfaces of the Lck dimer and 
the Itk complex. The remaining region on the SH2 domain that is involved in Lck dimer 
formation is primarily composed of three p-strands, pF, pE, and pD\ that do not participate 
in the Itk self-association event. In addition, the region of the SH2 domain involved in Lck 
dimer formation is on a different 'face' of the molecule, suggesting a different relative 
orientation of the self-associating dual domain containing fragments of Lck and Itk. 
The Itk SH3-SH2 interaction is specific 
A sequence alignment of nine SH2 domains including that of Itk is shown in Fig. 4. 
The regions of the Itk SH2 domain involved in the interaction with the Itk SH3 domain are 
poorly conserved among the SH2 domains examined. Specifically, the primary amino acid 
sequences in loops CD, EF and BG in the Itk SH2 domain differ from the corresponding loop 
regions of other non-Tec family SH2 domains. This observation prompted us to test the 
ability of the Itk SH3 and SH2 domains to bind SH2 and SH3 domains from other proteins. 
Exploiting the fact that the interaction occurs between the individual domains, we performed 
HSQC titration experiments with SH3 and SH2 domains from different parent proteins. In 
contrast to the results for the equimolar mixture of Itk SH3 and Itk SH2 (Fig. 2A), significant 
chemical shift perturbations are not observed for the Itk SH3 domain in the presence of the 
Grb2 SH2 domain (data not shown). To test whether the Itk SH2 domain showed similar 
36 
specificity, we performed a titration experiment with the Lck SH3 domain and the Itk SH2 
domain. Again, chemical shift perturbations were not observed. Therefore the SH3-SH2 
interaction appears to be specific for the SH3 and SH2 domains of Itk, and this specificity 
may be related to the non-homologous nature of the amino acid sequence in the CD, EF and 
BG loops. The exact nature of the contacts that mediate the SH3-SH2 recognition event must 
await the availability of the three-dimensional structure of the Itk SH2 domain. 
Further biophysical characterization of Itk SH32 
As is evident in the previously determined structure of the Itk SH3 domain (Andreotti 
et al., 1997), Trp 208 is centrally located and solvent exposed in the ligand binding pocket. 
For SH3 domains in general, this conserved Trp is indispensable for ligand binding; mutation 
removes the ability of the SH3 domain to mediate receptor-ligand interactions. We have 
demonstrated that the Itk SH3 binding pocket is involved in the interaction with the Itk SH2 
domain and that mutation of Trp 208 prevents SH2 binding (Figure IB). Thus, we anticipate 
that the sidechain of Trp208 may make direct contact with the Itk SH2 domain and that a 
comparison of NOE data for the SH3 domain alone and in the presence of the Itk SH2 domain 
may reveal interdomain NOEs. 
Two-dimensional homonuclear NOESY spectra were acquired and crosspeaks from 
the well resolved Itk SH3 Trp208 indole NH were analyzed. For the Itk SH3 domain alone 
(Figure 5A), the NOEs observed are due to the intraresidue p protons and aromatic protons, 
51 and Ç2. In Figure 5B, the SH2 domain was added in an equimolar ratio to the SH3 domain, 
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and an identical NOESY experiment was carried out. In addition to the intraresidue NOEs 
observed for the SH3 domain alone, NOEs are observed from the Trp208 sidechain NH to 
resonances at 4.3 ppm and 1.3 ppm. These NOEs are not intraresidue NOEs (backbone 
assignments indicate that the Itk SH3 Trp208 a proton resonates at 5.1 ppm and a Trp 
sidechain will not have a proton resonance at 1.3 ppm) and may therefore be interdomain 
NOEs between the indole NH proton in the SH3 binding pocket and protons on the surface 
loops of the SH2 domain. An identical two-dimensional homonuclear NOESY experiment 
was carried out for the Itk SH32 dual domain fragment (Figure 5C). The same non-
intraresidue NOEs from the Trp208 sidechain are observed (4.3 and 1.3 ppm) in addition to a 
weak upfield NOE at approximately 1.1 ppm. Filtered isotope experiments will be required 
to unambiguously identify the residues corresponding to these resonances and firmly 
establish that the observed NOEs are due to interdomain contacts. Nevertheless, given the 
solvent exposed nature of Trp 208 in the SH3 binding pocket, it is likely that the NOEs 
observed correspond to short proton-proton distances across the binding interface. 
Furthermore, the similarity in the NOE pattern for the Trp208 sidechain NH in both the 1:1 
SH3/SH2 complex and the Itk SH32 dual domain (Fig. 5B&C), together with the agreement in 
the *H and l5N resonance frequencies for each, suggests that the binding pocket of the Itk 
SH3 domain is occupied by the same region of the Itk SH2 domain in both cases. 
The translational self-diffusion coefficient (Ds) of a molecular species can be 
determined from the attenuation of NMR signals in a field gradient echo experiment (Stejkal 
& Tanner, 1965), and has been shown to be a useful means of characterizing the self-
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association of proteins under solution NMR conditions (Altieri et ai, 1995). NMR diffusion 
experiments were performed on 1.1 mM samples of Itk SH32 and Itk SH3*2(W208K) (Fig. 
6). The difference between the curves shown in Fig. 6, though small, is clearly significant 
with respect to the estimated experimental error. A log(I/I0) vs (A-8/3 )(ySG)2 plot will be 
linear for a homogenous, diffusing species, with the slope giving Ds. Inspection of Fig. 6 
shows that the curve for Itk SH3*2(W208K) deviates only slightly from linearity, whereas 
the curve for Itk SH32 deviates quite significantly over the last nine data points. Such non-
linearity is characteristic of molecular weight heterogeneity (von Meerwall, 1982; Haner & 
Schleich, 1989; Price et al., 1999). In such a case, the initial and final slope of the curve give 
maximum and minimum values of the distribution of Ds, and a fit to the entire curve provides 
an average value of the diffusion coefficient. Average values of Ds were obtained for both 
samples by fitting each complete data set to Eq. (1) via non-linear regression (see Table 1 and 
Materials & Methods). The WT data did not fit well to Eq.( 1 ). Consequently, the estimated 
error for Ds(WT)ave is relatively large. Therefore, the last nine points of the WT data were fit 
independently to estimate the limiting minimum value Ds(WT)min which would correspond to 
the largest molecular weight species in the solution. 
The data indicate that Itk SH32 is involved in oligomerization, probably a monomer-
dimer equilibrium, whereas the Itk SH3*2(W208K) mutant remains monomeric. The 
expected ratio of diffusion coefficients for a monomer-dimer system, based upon a simple 
hard-sphere hydrodynamic model for frictional coefficients is Ds(Dimer)/Ds(Monomer) = 
0.75 (Teller et al., 1979). Our observed ratio is somewhat higher: Ds(WT)mjn/Ds(W208K.)avc 
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= 0.79. It is overly simplistic to model the Itk SH32 dual domain as a hard sphere. If we 
regard the dual domain monomer itself as a string of two hard spheres (still a very crude 
model) we obtain from the hard-sphere hydrodynamic model Ds(Dimer)/Ds(Monomer) = 
0.77 for a tetrahedral packing arrangement, and Ds(Dimer)/Ds(Monomer) = 0.81 for a square 
packing arrangement. Both cases are in reasonable agreement with the observed ratio. These 
results are consistent with the uniformly larger linewidths observed in the HSQC spectrum of 
Itk SH32 relative to the corresponding linewidths in the HSQC spectrum of the Itk 
SH3*2(W208K) mutant (see Fig. 1A&B). Additionally, intramolecular contacts between the 
SH3 and SH2 domains within a single dual domain fragment are unlikely due to steric 
limitations (Nam et al., 1996; Gosser et al., 1995; Maignan et al., 1995; Eck et al., 1994; Xu et 
al., 1999; Fushman et al., 1999). 
The presence of an Itk SH32 dimer in solution was also detected using analytical 
ultracentrifugation. Equilibrium sedimentation was performed on Itk SH32 and the Itk 
SH3*2(W208K) mutant to determine that the Itk SH32 self-association occurs at 
concentrations lower than that used for NMR and to estimate the dissociation constant (Kj). 
Sedimentation behavior was evaluated at three different concentrations: 26.6 nM, 13.3 nM, 
and 6.65 |iM for both Itk SH32 and Itk SH3*2(W208K). With increasing concentration the 
apparent molecular mass for Itk SH32 increased, whereas that for Itk SH3*2(W208K) 
remained constant. This verifies the existence of a monomer-dimer equilibrium for Itk SH32 
as determined by NMR, and confirms that the Itk SH3*2(W208K) mutant does not self-
associate. Using the equilibrium sedimentation data, we have determined that the dissociation 
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constant (KJ for dimerization of Itk SH32 is approximately 25 pM. The measured Kj is 
consistent with the exchange regime observed in the NMR data (intermediate to fast), which 
gives a Kd > I0'7 M, assuming diffusion-limited molecular association. 
Ligand Binding Studies 
Inspection of the SH3 and SH2 domain surfaces responsible for mediating the SH3-
SH2 interaction suggests that conventional SH3 and SH2 ligands may play a role in regulating 
the intermolecular interaction of the Itk SH32 dual domain. The conserved aromatic SH3 
binding pocket is used for both polyproline recognition and SH2 binding which suggests that 
the two binding events may be mutually exclusive. In contrast, comparison of the region of 
the SH2 domain that contacts the SH3 domain with that involved in phosphopeptide 
recognition reveals a much smaller shared surface around the pY+3 binding pocket (Figure 
3A). Thus, given the overlap in the binding sites on both the SH3 and SH2 domains, we 
compared peptide ligand binding to the isolated domains and to the self-associating dual 
domain. 
The proline-rich peptide (QQPPVPPQRPMA) and the phosphotyrosine-containing 
sequence (ADpYEPPPSNDE) were synthesized by standard solid phase methods and 
purified to homogeneity. Both peptide sequences are derived from Slp-76, a phosphoprotein 
that binds to full-length Itk via interactions with both the SH3 and SH2 domains (Bunnell et 
al., 1996; Bunnell et ai, 2000; Su et ai, 1999). Four separate HSQC titrations were carried 
out to determine dissociation constants for each peptide bound to its corresponding target 
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domain in isolation and in the context of the self-associating SH32 dual domain. Based on 
chemical shift perturbation assays where the peptide/protein ratio varied between 0 and 3, a 
Kd of 0.77 - 0.16 mM for the isolated SH3-polyproline peptide interaction and a Kd of 0.41 -
0.12 mM for the isolated SH2-pTyr peptide interaction were determined. The affinities of 
these physiological peptides are less than the binding affinities observed for peptides selected 
from a library screening yet are consistent with competition experiments reported previously 
for the same peptides binding to the domains of Itk (Bunnell et al. 2000). The corresponding 
determination of peptide binding affinities to the Itk SH32 dual domain is complicated by 
concomitant dimer dissociation. 
For binding of the pTyr-containing sequence to the SH2 domain of Itk SH32, we were 
able to monitor chemical shift changes for residues that make up the peptide binding site but 
do not participate in stabilizing the dimer interface. The chemical shift values of this subset 
of residues are unaffected by dimer dissociation yet are perturbed upon addition of ligand 
allowing for an estimate of the Kd for pTyr peptide binding to the dual domain. Binding 
curves for binding of the pTyr peptide to both the isolated Itk SH2 domain and the Itk SH32 
dual domain are shown in Figure 7. The difference in the curves reveals a lower binding 
affinity for interaction of the pTyr-peptide with the self-associating dual domain as 
compared to the single SH2 domain. This result is consistent with our model for 
homodimerization of Itk SH32 where part of the peptide binding site on the SH2 domain 
contacts the SH3 domain in an intermolecular fashion (Figure 3A) and therefore reduces 
peptide binding affinity. This result is in contrast to previous studies (Gosser et al., 1995) 
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where peptide binding to isolated SH2 and SH3 domains was indistinguishable from binding 
to an SH32 dual domain. 
Overlap in the binding sites for the SH2 domain and polyproline peptide ligand on the 
Itk SH3 domain made estimation of a dissociation constant unreliable. Each residue involved 
in peptide binding also experienced chemical shift perturbation as a result of dimer 
dissociation and was consequently not a faithful representation of peptide association. We 
therefore assessed the degree to which peptide association shifted the equilibrium toward the 
monomelic form of the Itk dual domain, i.e., toward the Itk SH3*2(W208K) chemical shifts. 
A comparison of the resonance frequency of a given residue in an HSQC spectrum of the 
ItkSH3*2(W208K) mutant, Itk SH32, and Itk SH32 in the presence of excess polyproline 
peptide (Figure 8A) reveals a shift toward monomer when peptide is present. This suggests 
that the Slp-76 proline-rich peptide partially displaces the SH2 domain from the SH3 binding 
pocket at the concentrations tested. In contrast, a similar analysis for pTyr-peptide binding 
reveals very little if any shift toward the monomeric state (Figure 8B). This suggests that 
phosphopeptide does not dissociate the dimer to a significant extent. The extent to which the 
pTyr-containing peptide binds to Itk SH32 (Figure 7) may be due to contacts between the 
pTyr residue and the pTyr binding pocket on the SH2 domain which lies outside of the SH3 
binding surface. 
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Conclusions 
Self-association of the SH3 and SH2 dual domain-containing fragment of Itk has been 
examined. Chemical shift perturbation data indicate a contiguous binding surface that differs 
from the Lck dimer interface previously observed. We have also shown on the basis of NMR 
diffusion and linewidth data that Itk SH32 forms a homodimer under NMR solution 
conditions. A point mutation that abrogates the interaction also completely eliminates 
dimerization. The region of the SH3 domain involved in the interaction encompasses the 
conserved ligand binding pocket that generally contacts polyproline sequences in the SH3-
mediated interactions studied to date. The interaction surface on the SH2 domain extends 
along a ridge formed by residues in four loop regions. Notably, the amino acid sequences of 
the SH2 loops that contact the SH3 binding site do not resemble the standard PXXP motif 
that is regarded as the canonical SH3 ligand. Furthermore, the SH3 ligand within this SH2 
domain does not arise from a contiguous amino acid sequence that is the hallmark of the 
prototypical SH3 ligand. It is conceivable that the loops on the SH2 domain adopt a spatial 
arrangement that can mimic the SH3-PXXP interaction. A detailed understanding of this 
molecular recognition will require further structural analysis. 
The SH2 residues involved in the interaction partially overlap those responsible for 
phosphotyrosine peptide binding and the SH3 residues that mediate polyproline peptide 
binding and SH2 recognition are nearly identical. We have demonstrated that the binding 
affinity of a pTyr-containing peptide for the Itk SH2 domain diminishes in the presence of 
self-association and that excess peptide ligand for either the SH3 or SH2 domain does not 
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completely abrogate self-association. Given the fact that the binding assays were done using 
short peptide models, it is conceivable that the ltk/Slp-76 interaction within the cell may 
effectively compete with Itk self-association. Certainly variations in local concentration as a 
result of co-localization of two signaling proteins could modulate affinity to favor either self-
association or interaction with exogenous protein. 
The mechanism of Tec family kinase activation following receptor stimulation 
appears to follow a series of steps that include membrane redistribution and phosphorylation 
of key tyrosine residues. Stimulation causes an increase in levels of phosphatidylinositol 
3,4,5-trisphosphate which is a high affinity ligand for the PH domain of the Tec kinases 
(Carpenter & Cantley, 1996; Rameh et al., 1997). Studies of Btk regulation have suggested 
that the PH domain-phosphatidylinositol interaction is responsible for localizing Btk to the 
plasma membrane where activation proceeds (Scharenberg et al., 1998; Kawakami et al., 1994; 
Li et al., 1997; Bolland et al., 1998). Whether Itk is recruited to the membrane in the same 
fashion or is constitutive^ present at the membrane while other signaling partners are co-
localized remains uncertain (Shan & Wange, 1999). In any event, an intact PH domain 
(capable of membrane association) appears to be a prerequisite for Tec family kinase function 
(Hyvônen & Saraste, 1997). Once membrane localized, the Tec kinases are phosphorylated 
by co-localized, activated Src kinases (Rawlings et al., 1996) on a tyrosine residue in the 
kinase domain (Y551 in Btk). This transphosphorylation event occurs rapidly following 
stimulation and is followed by a slower autophosphorylation event on a conserved tyrosine 
residue in the ligand-binding pocket of the SH3 domain (Y223 in Btk) (Nisitani et al., 1999). 
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This SH3 autophosphorylation step appears to be required for full kinase activation. Our 
current model of the conformational state of inactive Itk has the SH3 binding-pocket occupied 
by the proline-rich region of the adjacent TH domain in an intramolecular fashion (Andreotti 
et al., 1997). A mechanism for displacement of the intramolecular proline ligand seems 
necessary for autophosphorylation to occur. 
Based on the SH3-SH2 interaction we have described, we envision that an 
intermolecular association between the SH2 domain of one membrane bound protein and the 
SH3 domain of an adjacent molecule might effectively displace the intramolecular proline 
sequence from the SH3 binding pocket to promote kinase activation. The Itk Pro-SH3 
fragment, in which the SH3 pocket is occupied by the proline-rich stretch (Andreotti et al., 
1997), binds to the Itk SH2 domain in a manner that is indistinguishable from that of the 
SH3-SH2 interaction described. Thus, it is conceivable that the SH3-SH2 interaction could 
compete with the intramolecular proline sequence for the binding pocket of the SH3 domain. 
Removal of the intramolecular proline sequence by a transient intermolecular SH3-SH2 
interaction could accomplish the following: accessibility to the SH3 binding pocket for either 
association of exogenous ligand (high local concentration may compete with homodimer) or 
tyrosine autophosphorylation. As well, the SH3-SH2 interaction would reveal the internal 
proline sequence for association with other cellular ligands in the receptor mediated signaling 
pathway. The relatively weak affinity (-25 jxM) observed for the self-association of Itk 
SH32 is entirely consistent with such a regulatory role. The effective affinity of the 
intermolecular interaction, which is related to the extent of homodimerization, could be 
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controlled by changes in the local concentration of Itk at the membrane during different 
signaling events. 
Homodimerization has previously been observed for a fragment of another Tec kinase 
family member. The PH domain of Btk crystallizes as a dimer in the asymmetric unit 
(Hyvônen & Saraste, 1997) and it has been proposed that dimerization of PH domains on the 
membrane could be an important step in the activation of Btk (Baraldi et al., 1999). It is 
conceivable that additional regulatory domains outside of the PH domain may be involved in 
stabilizing an oligomeric state at the membrane that ultimately results in active kinase. 
Btk has garnered tremendous interest due to the fact that mutations in the gene coding 
for this protein cause the severe hereditary immunodeficiency, X-linked agammaglobulinemia 
(XLA). The disease is characterized by extremely low immunoglobulin levels due to a B cell 
differentiation defect (Mattsson et al., 1996; Smith et al., 1994). DNA mutations causing 
XLA occur in all five domains of Btk (PH, TH, SH3, SH2 & kinase) which implies that all 
five domains of the protein are required for proper regulation and signaling (Vihinen et al. & 
Smith, 1998). Nine missense mutations have been mapped to the SH2 domain of Btk and the 
positions of these point mutations are indicated on the Itk sequence (Figure 4). Also 
highlighted in Figure 4 are those SH2 residues for which the amide resonance frequencies 
change upon addition of the Itk SH3 domain. There is a striking correlation between the Btk 
SH2 XLA causing mutations and the loops of the Itk SH2 domain that we have determined 
mediate the observed SH2-SH3 interaction. Six of the nine SH2 loss of function mutations 
occur at positions directly involved in the SH3-SH2 interaction (as determined by chemical 
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shift mapping) while two missense mutations are immediately adjacent to an interacting 
residue. It has been previously suggested that a subset of the XLA causing mutations may 
disrupt the ability of the SH2 domain to bind phosphotyrosine-containing substrates 
(Mattsson et al., 2000; Vihinen et al. & Smith, 1998). We would suggest that the XLA 
causing mutations may also abrogate the SH3-SH2 interaction described here. Certainly, the 
striking correlation between the surface loops of the Itk SH2 domain that we have determined 
mediate an interaction with the Itk SH3 domain and the XLA causing mutations identified to 
date suggests that the SH3-SH2 interaction may play an important role in the activation and 
subsequent signaling of Tec family kinases. The interaction we have described here has 
revealed a novel binding capability of the ubiquitous SH3 and SH2 domains and has identified 
a new interaction within the Tec kinase family that may modulate aspects of hematopoetic 
cell signaling. 
Materials and Methods 
Protein expression and purification 
Inserts encoding the desired domains of Itk were generated by PCR and were 
subcloned into the BamHI site of pGex-2T to generate glutathione-5-transferase (GST) fusion 
proteins. The SH3 and SH32 5' primers encode Itk products beginning at amino acid 171, and 
the SH2 5' primer begins at amino acid 231. The SH3*2(W208K) mutant was constructed as 
described previously (Andreotti et al., 1997). All fusion proteins were produced in E. coli 
strain BL21(DE3), and grown at 37°C in LB medium or modified M9 minimal medium; 50 
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Hg/ml ampicillin. The modified M9 minimal medium used for the preparation of uniformly 
I5N/,3C double labeled or l5N single labeled protein contained l5N-enriched ammonium 
chloride (Ig/L, Cambridge Isotope Laboratories) and either l3C-enriched glucose (2g/L, 
Cambridge Isotope Laboratories) or unenriched glucose as sole nitrogen and carbon sources. 
When the optical density (600 nm) reached 0.6, protein expression was induced by addition 
of 1 mM isopropyl p-D-thiogalactopyranoside (IPTG) and the temperature was reduced to 
30°C. Seven hours post-induction in LB medium or 17 hours post-induction in M9 minimal 
medium the cells were collected by centri(ligation, resuspended in 50mM potassium 
phosphate buffer, pH 7.4, 75 mM NaCl, and 2 mM DTT, lysozyme was added, and the cells 
were stored at -80°C for 12 hours. Cells were lysed upon thawing at room temperature with 
addition of protease inhibitor (ImM PMSF) and DNAse (50 ul of 10 mg/ml stock). The cell 
lysate was clarified by centrifugation, and the resulting supernatant was purified using a 
glutathione-agarose column (Sigma). The fusion proteins were eluted with 5 mM glutathione, 
50 mM potassium phosphate buffer, pH 7.4, 75 mM NaCl, 2 mM DTT, and 0.02 % NaN3. 
Proteins were concentrated and loaded onto a gel filtration column (Sephacryl S-100 HR, 
Amersham Pharmacia Biotech). Fractions containing the fusion proteins were combined, and 
the concentration of NaCl was increased to 150 mM for thrombin cleavage to remove the 
GST tag. The proteins were placed at room temperature for approximately 1-2 hours (Itk 
SH2) or 12 hours (Itk SH3, SH3SH2) for complete cleavage. After cleavage, the proteins 
were passed over a glutathione column to remove GST, concentrated and loaded onto the gel 
filtration column. Fractions of protein were collected, analyzed for purity by SDS-
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polyacrylamide (15%) gel electrophoresis and concentrated to 1-2 mM for NMR. All 
samples were stored at 5° C, except when NMR spectra were acquired. 
NMR spectroscopy 
NMR spectra were acquired using a Bruker DRX500 spectrometer operating at 'H 
frequency of 499.867 MHz. A 5 mm triple resonance ('H/I3C/I5N) probe with XYZ field 
gradients was used for all experiments. All spectra were collected at 298 K unless otherwise 
indicated. A gradient-enhanced HSQC experiment with minimal water saturation (Mori et al., 
1995) was used for all *H-I5N correlation experiments. 3D l5N-edited TOCSY and l5N-edited 
NOES Y (Talluri & Wagner, 1996) spectra were acquired for a l5N labeled Itk SH2 sample 
using mixing times of 100 ms and 72 ms, respectively. 3D CBCA(CO)NH, HNCACB 
(Muhandiran & Kay, 1994), and HCCH-TOCSY (Kay etal., 1993) spectra were acquired for 
an ,:>N/I3C doubly labeled sample of Itk SH2 using standard experimental protocols. The 3D 
data were used to obtain sequential assignments of the backbone 'H and l5N shifts of the SH2 
domain. Sequential assignments for the Itk SH3 domain were completed previously 
(Andreotti et al., 1997). Additional homonuclear 2D NOESY spectra were collected of Itk 
SH3, an equimolar SH3/SH2 mixture and the SH3/SH2 dual domain (Itk SH32), to identify 
NOEs involving W208 of SH3. For these spectra a mixing time of 175 ms and a sample 
temperature of 301 K were used. Data were processed by use of NMRPipe (Delaglio et al., 
1995) software, and the NMRView (Johnson & Blevins, 1994) software package was used 
to facilitate the assignment process. 
50 
NMR Diffusion Measurements 
The self-diffusion coefficient Ds was measured at 298 K for wild type and mutant 
dual domain protein samples by use of a gradient longitudinal encode-decode (LED) 
experiment (Tanner, 1970; Altieri et al., 1995). The standard LED pulse sequence was 
modified by the use of bipolar encode-decode gradient pulses (Wider et al., 1994) and by the 
addition of a WATERGATE module (Piotto et al. 1992). For each sample, a series of ID 
NMR spectra was acquired during which the strength of the rectangular encode-decode 
gradient pulses was incremented from 0.6 to 35 G/cm. The NMR signal amplitude of a 
homogenous diffusing species is attenuated according to the Stejkal-Tanner relation (Stejkal & 
Tanner, 1965) 
I = I0 exp[-(YÔG)2 (A - S/3) Ds] (1), 
where G is the encode-decode gradient strength, I is the observed NMR signal intensity, I0 is 
the signal intensity for G = 0, y is the *H gyromagnetic ratio, 6 is the gradient duration, A is 
the time between encode and decode pulses and Ds is the self-diffusion coefficient. Each 
series of ID experiments was repeated four times in order to estimate the experimental error. 
A portion of the spectral envelope, consisting of the methyl proton region, was integrated to 
obtain the signal intensity. The z-axis gradient coil of a Bruker 5 mm TXI triple axis gradient 
probe head was used to generate the gradient pulses. The spectrometer temperature 
controller was calibrated using a standard methanol sample (van Geet, 1970). The gradient 
strength G was calibrated by measuring the decay of residual HOD in 99.98% D20, using the 
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literature value of Ds = 1.902 x 10"5 cm2/sec (Longsworth, 1960), and fitting the data to Eq. 
(1) by non-linear regression. The procedure was tested by measuring Ds for 15 mM 
lysozyme, giving a value of 1.07 x 10"6 cnr/sec (data not shown), in good agreement with the 
reported value of 1.08 x 10"6 cnr/sec (Altieri et al., 1995). 
Analytical Equilibrium Ultracentrifugation 
Analytical ultracentrifugation experiments were performed on a Beckman Optima XL-
A ultracentrifuge. Itk SH32 and Itk SH3*2(W208K) samples were prepared as described for 
the NMR samples; however, concentrations of 6.65 pM, 13.3 jiM, and 26.6 nM were used. 
Protein samples were centrifuged at least 12 hours before data collection. Samples at each 
concentration were sedimented at rotor speeds of 22,000, 26,000, and 30,000 rpm, and the 
temperature was maintained at 25°C. Stepwise radial scans were performed at 280 nm and 
each reading was an average of 30 points with nominal spacing of 0.001 cm between radial 
positions. The absorbance readings were measured at 1 hour intervals to ensure that 
equilibrium had been reached. Three scans for each rotor speed were averaged, and the data 
were used to calculate the apparent molecular weight (Mw) for each concentration. The Mw 
is a measure of the average molecular weight of the monomer-dimer solution at equilibrium for 
the different concentrations: 
M w = f u M u + ( l - f u ) M D  (2) 
Where fM and (l-fM) are the weight fractions of monomer and dimer respectively, and Mm and 
Mq are the molecular weights of monomer and dimer. The data was plotted as molecular 
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weight versus concentration and a curve was obtained by a nonlinear least squares fit to 
Equation 2. Equation 3 can be substituted for fM in Equation 2 and the equilibrium constant 
(Kd) was extracted from the fitted curve. 
- K t + W + i K f r  
f
" 4Pr ( '• 
where Pt is the total protein concentration and Kd is the equilibrium dissociation constant. 
The curve was constrained to the monomer molecular weight obtained for Itk 
SH3*2(W208K) from ultracentrifugation data (14.8 kDa). This weight is lower than the 
calculated molecular weight of 19.7 kDa. Both the Itk SH32 and Itk SH3*2(W208K) samples 
were analyzed by NMR prior to ultracentrifugation experiments and the number of peaks in 
the HSQC spectra agreed with the corresponding amino acid sequences. Therefore, Itk SH32 
and ItkSH3*2(W208K) do not exhibit ideal hydrodynamic behavior during 
ultracentrifugation. 
NMR Binding Assays 
Solutions of l5N-labeled Itk SH2, SH3 and SH32 dual domain were prepared in 400 
nL of phosphate buffer as described above. The solutions were 0.5 mM for the single 
domain proteins and 1.0 mM for the dual domain protein, as determined by UV-visible 
absorption at 280 nm. Stock solutions of each peptide were prepared in 20 nL H]0. The 
peptide solutions were prepared (as determined by the dry weight of lyophilized peptide) to 
reach a threefold molar excess of peptide at the end of each titration, neglecting the small 
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volume of added peptide. For each protein sample, 2 gL aliquots of peptide solution were 
added so that the molar ratio of peptide to protein was increased from 0 to 3 in 11 steps. 
After each addition, an i5N-'H HSQC spectrum was acquired. 
The NMR spectra were examined and peaks were selected that displayed significant 
chemical shift perturbation and were well resolved in both single and dual domain spectra 
over the course of the titrations. It should be noted that for the Itk SH32-pTyr peptide 
titration, peaks corresponding to the peptide binding region that lay outside of the dimer 
interface were used to generate binding curves. The chemical shift perturbations in both the 
'H and i5N dimensions were used to obtain binding curves. The chemical shift of 
protein/1 igand system in fast exchange is described by Equation 4 (Lian & Roberts, 1993): 
where 6obs is the observed protein chemical shift, 5P is the protein chemical shift in the 
absence of ligand, SPL is the protein chemical shift in the presence of excess ligand, LT is the 
total ligand concentration, PT is the total protein concentration and Kd is the equilibrium 
dissociation constant. Figure 7 shows representative plots of 8ob vs. LT. The parameters Kd 
and 5pl were determined by fitting the data to Equation 4 by non-linear regression. For each 
protein/1 igand combination (except SH32 dual domain and polyproline ligand) at least three 
independent Kd values were determined from which average values and estimated 
experimental errors (three standard deviations) were calculated. 
r 
(4), 
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Table 1. 
Self-diffusion coefficients of 1.5 mM Itk SH32 and Itk SH3*2(W208K) at 298 K 
Protein Ds ( x 10"7 cm2/sec) Ds/Ds(W208K)avc 
(W208K)ave 8.59 ± 0.09 1.00 
(WT)avc 8.35 ±0.21 0.97 
(WT)min 6.81 ±0.07 0.79 
Figure I. 'H-I5N HSQC spectra of purified, recombinant (A) Itk SH32, (B) Itk 
SH3*2(W208K), (C) Itk SH3 and (D) Itk SH2. For each sample protein concentration was 
between 1 and 1.3 mM in 50 mM potassium phosphate, pH 7.4, 75 mM NaCl, 2 mM DTT, 
0.02% NaNs, 25 °C. *H and l5N chemical shifts are referenced to external DSS at 0 ppm. 
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Figure 2. Chemical shift changes in the isolated l5N-labeled SH3 (A) and SH2 (B) domains 
of Itk induced upon addition of either the unlabeled Itk SH2 or SH3 domain, respectively. 
Left panels, Selected expanded regions of 'H-I5N HSQC spectra (blue) of Itk l5N-SH3 (A) or 
Itk i5N-SH2 (B) superimposed on *H-I5N HSQC spectra (red) of the 1:1 complexes of 
labeled Itk l5N-SH3 and unlabeled Itk SH2 (A) or Itk l5N-SH2 and unlabeled Itk SH3 (B). 
Arrows show the direction of the observed shifts. All residues with shifts greater than 0.1 
ppm in either the proton or nitrogen dimension were considered significant. The titration of 
the unlabeled Itk Pro-SH3 fragment and Itk l5N-SH2 results in identical shifts to those 
observed in (B). Right panels, Residue-by-residue differences (thick bars) in l5N (top) and 
*HN (bottom) Itk SH3 (A) and SH2 (B) chemical shifts. The plotted values correspond to 
chemical shift changes observed in the dual domain Itk SH32 as compared to the mutant Itk 
SH3*2(W208K). Aô = (5free- ôbound) where 5free refers to resonances in Itk SH3*2(W208K) 
and 8bound refers to the chemical shift values of l5N-labeled dual domain Itk SH32. The thin 
lines indicate residues for which line broadening occurred to an extent that the HSQC signal 
disappears. For 2A, the last two columns are the chemical shift perturbations of the W208 
and W209 side chain indole *HN and l5N resonances. (For W208, 6free for the singly 
expressed SH3 domain was used to calculate AS.) 
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Figure 3. Surface maps of the Lck SH32 dual domain fragment (Eck et al., 1994) (A) The 
residues involved in the Itk SH32 self-association as determined by chemical shift 
perturbations (arrived at by analysis of the isolated domain titration experiments as well as 
comparison of the HSQC spectra for wild type Itk SH32 and mutant Itk SH3*2) are indicated 
in red while residues that do not show any change in their resonance frequencies upon 
addition of binding partner are in blue. Labels in the SH3 domain include Lck Trp 97, which 
corresponds to Itk Trp 208, and the variable n-Src and RT loops that line the conserved 
aromatic binding pocket. The phosphotyrosine peptide binding site on the SH2 domain is 
indicated by labeling of the phosphotyrosine (pY) and carboxy-terminal (pY+3) pockets. 
The EF, BG, AB and CD loops are labeled accordingly. (B) Comparison of the surfaces 
mediating the SH3-SH2 interaction in the Lck dual domain crystal structure (yellow) (Eck et 
al., 1994) and the Itk SH3-SH2 interaction (red, as in A). Orange indicates an overlap in the 
regions involved in each interaction. The surface maps were calculated using Molecular 
Analysis and Molecular Display (MolMol) (Koradi et al., 1996) from the PDB file 1LCK. 
EFloop 
RTloop 
Figure 4. Aligned sequences of the SH2 domains from nine different proteins. The Tec 
family SH2 domains (Itk and Btk) are on the first two lines. Numbering refers to full-length 
Itk. The location of regular secondary structure is based on the Lck sequence (Eck et al., 
1994). Residues conserved among SH2 domains are in blue and the portions of the Itk 
sequence highlighted in red are the SH2 residues that are involved in the interaction with the 
Itk SH3 domain as determined by chemical shift perturbations. Asterisks indicate the position 
of the Btk missense mutations that have been identified to date in patients with XLA. 
Underlined residues mediate pTyr peptide binding in other SH2 domains for which complex 
structures have been solved. Accession numbers for each sequence are as follows: Itk: 
Q03526, Btk: P35991, Blk: NP_031575, Src: TVCHS, Fyn: CAB 10788, Lck: P06239, Abl: 
AAB60393, Grb2: NP002077, Csk: NP004374. 
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Figure 5. Two-dimensional homonuclear NOESY spectra for (A) Itk SH3, (B) equimolar 
mixture of Itk SH3 and Itk SH2, (C) Itk SH32 dual domain-containing fragment. For each 
spectrum the region shown includes the indole NH resonance for Trp 208 in the SH3 binding 
pocket (10.08 ppm for the SH3 domain alone (A) and 10.2 ppm when in the presence of SH2 
domain (B&C)). For each of the three samples, intraresidue NOEs to the neighboring 
aromatics (7.1, 7.3 ppm) and the Trp (3 protons (2.8, 3.0 ppm) are assigned and indicated by 
horizontal lines. Additional non-intraresidue NOEs from the Trp208 indole NH are observed 
in (B) and (C) and are boxed. 
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Figure 6. NMR self-diffusion data for Itk dual domains at 298K. The Itk SH32 and Itk 
SH3*2(W208K) mutant data are indicated by filled and open circles, respectively. The data 
are the average values of normalized peak integrals obtained from four replicate experiments. 
Symbols are as defined in Materials & Methods. The error bars represent three times the 
standard deviation of the data from the individual experiments. In many cases the error bars 
are obscured by the data symbols. 
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Figure 7. Examples of chemical shift titration data used to obtain the binding constant K<] 
for protein/peptide complexes. Open triangles denote data for residue Y64 in the Itk 
SH2/ADpYEPPSNDE complex. Closed circles denote data for Y64 in the Itk 
SH32/ADpYEPPSNDE complex. The solid curves were obtained by fitting the data to 
Equation 4 via non-linear regression. The estimated K<j for the Itk SH32/ADpYEPPSNDE 
interaction is 1.78 - 1.09 mM. The large error reflects difficulties in accurately monitoring 
chemical shift changes due to extensive line broadening associated with the Itk SH32 dual 
domain fragment. 
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Figure 8. Overlays of three HSQC spectra: dark blue, monomelic Itk SH3*2(W208K); red, 
dimeric Itk SH32; light blue, Itk SH32 + excess peptide ligand. When comparing (A) and 
(B), the dark blue and red spectra are identical, and the difference in the light blue spectra is 
due to addition of either polyproline peptide (SH3 ligand) or phosphotyrosine-containing 
peptide (SH2 ligand). (A) light blue peaks represent Itk SH32 in the presence of 3 fold 
excess polyproline peptide. To assess the degree to which peptide binding to the SH3 
domain causes dimer dissociation, we monitor an SH2 resonance (e.g., 1283) that is affected 
only by changes in the monomer-dimer equilibrium and not peptide association. Peptide 
binding to the SH3 domain of Itk SH32 dual domain causes SH2 resonances to shift toward 
the resonance frequency associated with monomer (dark blue). (B) Likewise, to assess the 
affect of phosphotyrosine peptide binding on self-association of Itk SH32, we follow the SH3 
domain resonances (e.g., A191 ). Itk SH32 in the presence of 3 fold excess phosphotyrosine-
containing peptide, light blue, does not exhibit a significant shift in resonance frequency but 
rather retains the resonance frequency of the ItkSH32 self-associating dual domain, red. It 
should be noted that the resonance frequencies shown for Itk SH3*2(W208K) are identical to 
those for the isolated SH3 and SH2 domains and are therefore not affected by the point 
mutation. 
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CHAPTER 3. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl 
isomerase cyclophilin A 
A paper published in the Proceedings of the National Academy of Sciences, U.S.A (2002) 99, 
1899-1904. 
Kristine N. Brazin, Robert J. Mallis, D. Bruce Fulton and Amy H. Andreotti 
Abstract 
Interleukin-2 tyrosine kinase (Itk) is a non-receptor protein tyrosine kinase of the Tec 
family that participates in the intracellular signaling events leading to T cell activation. Tec 
family members contain the conserved SH3, SH2 and catalytic domains common to many 
kinase families, but are distinguished by unique sequences outside of this region. The 
mechanism by which Itk and related Tec kinases are regulated is not well understood. Our 
studies indicate that Itk catalytic activity is inhibited by the peptidyl prolyl isomerase 
(PPIase) activity of cyclophilin A (CypA). NMR structural studies combined with 
mutational analysis show that a proline-dependent conformational switch within the Itk SH2 
domain regulates substrate recognition and mediates regulatory interactions with the active 
site of CypA. CypA and Itk form a stable complex in Jurkat T cells that is disrupted by 
treatment with cyclosporin A (CsA). Moreover, the phosphorylation levels of Itk and a 
downstream substrate of Itk, PLCyl, are increased in Jurkat T cells that have been treated 
with CsA. These findings support a novel mode of tyrosine kinase regulation for a Tec 
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family member and provide a molecular basis for understanding a cellular function of the 
ubiquitous PPIase, CypA. 
Introduction 
Normal cell growth depends upon the precise control of protein tyrosine kinase 
activity ( I ). For certain families of kinases, the mechanism of catalytic regulation is well 
understood. Structures of Src tyrosine kinases (2,3) reveal intramolecular interactions 
mediated by the Src homology 2 (SH2) and Src homology 3 (SH3) domains that control 
catalytic activity of the neighboring kinase domain. Specifically, distortion of the Src kinase 
active site is achieved in part by SH2 binding to a phosphorylated tyrosine residue in the C-
terminal tail of Src (4). For other families of kinases, the mechanistic details of catalytic 
regulation remain elusive. In particular, the Tec family of non-receptor tyrosine kinases (5) 
display distinguishing characteristics that point to an alternative mode of regulation. The Tec 
family kinases modulate hematopoetic cellular responses to external stimuli (6). The T-cell 
specific Tec family member, Interleukin-2 tyrosine kinase (Itk), (7,8) plays a role in the 
maturation of thymocytes, is required for intracellular signaling following T cell receptor 
(TCR) cross!inking, and is involved in generation of second messengers that mediate 
cytoskeletal reorganization (9). Itk is homologous to Src in the region spanning the SH3, SH2 
and kinase domain but lacks the Src C-terminal tail that contains the regulatory tyrosine. 
However, activation of Itk depends upon SH2-mediated interactions with phosphorylated 
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signaling partners (9) such as Slp-76 (10) and LAT (11) suggesting a regulatory role for the 
Itk SH2 domain despite the absence of a Src-like C-terminal regulatory tyrosine residue. 
The Src regulatory mechanism highlights the role of molecular switches in controlling 
cellular signaling pathways. Well-studied covalent modifications such as phosphorylation 
generate recognition sites that affect the activity and binding behavior of many signaling 
proteins (1, 12-14). Moreover, there are potential regulatory switches intrinsic to 
polypeptides such as the cis/trans isomerization of peptide bonds preceding the imino acid 
proline (15,16). In native proteins, the local environment surrounding a proline residue, as 
well as the overall tertiary structure, influence the relative energies and therefore the relative 
population of the cis and trans conformers. The majority of folded proteins for which three-
dimensional structural information has been gathered contain trans prolyl imide bonds. The 
cis conformation occurs at a frequency of approximately 6% in folded proteins ( 17) and a 
small subset of proteins are conformational^ heterogeneous with respect to cis/trans 
isomerization ( 18-21 ). Furthermore, the activation energy for interconversion between cis 
and trans proline is high (~20 kcal/mol) leading to slow interconversion rates (22). This 
barrier is a rate-limiting step in protein folding and may serve to kinetically isolate two 
functionally and conformational^ distinct molecules. These special properties, and the fact 
that many proline residues are highly conserved in homologous protein sequences, suggest 
that prolines may play a role in con former-specific recognition and function. 
Three distinct enzyme families have been identified that catalyze the cis/trans 
isomerization of prolyl imide bonds. These peptidyl-prolyl cis/trans isomerases (PPlases) 
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(23,24) consist of the cyclophilins (CyP), FK506 binding proteins (FKBPs) and the 
parvulins (25,26). CypA and FKBP12 are the intracellular protein targets of the 
immunosuppressive natural products CsA and FK506, respectively (27). These small 
molecules inhibit PPIase activity and block T cell activation. However, the 
immunosuppressant activity of these small molecules derives not from inhibition of 
isomerase activity but rather from interruption of signaling events by the inhibitor-PPIase 
complexes themselves (28). The binary CsA-CypA and FK.506-FKBP12 complexes bind to 
and inhibit calcineurin, the serine/threonine phosphatase responsible for dephosphorylation 
and subsequent nuclear translocation of the IL-2 transcription factor, nuclear factor of 
activated T-cells (29,30). The PPIase inhibitors, CsA and FK506, have shed considerable 
light on immunosuppression as well as the signal transduction pathways involved in T cell 
signaling, yet the normal cellular roles of the PPIases remain unclear. While recent efforts 
have identified several PPIase-mediated cellular processes (31-37), the range of normal cellular 
functions controlled by the ubiquitous PPIases and the molecular basis for their role in 
regulating signaling cascades have not yet been fully elucidated. 
The cellular targets of the PPIases are likely folded proteins that contain a 
conformational^ heterogeneous proline residue. We now present a structural analysis of Itk 
that places this protein among those that exhibit multiple, well-defined, low energy 
conformations in solution. A single prolyl imide bond is responsible for the observed 
conformational heterogeneity within Itk and we show that this proline-dependent 
conformational switch directly regulates Itk substrate recognition. Moreover, we demonstrate 
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that the PPIase, CypA, catalyzes the cis/trans isomerization of the conformationally 
heterogeneous prolyl imide bond within Itk. In vitro and in vivo functional data reveal a 
stable CypA-Itk complex in T cells and point to a role for CypA in repressing Itk kinase 
activity. Together, these data support a novel mode of non-receptor tyrosine kinase 
regulation and provide a molecular basis for understanding a cellular function of the PPIase, 
CypA. 
Materials and Methods 
Protein expression and NMR Spectroscopy. Full-length Itk cDNA (7) for PCR 
amplification was a gift from Leslie J. Berg (University of Massachusetts Medical School). 
Protein samples for NMR were expressed and purified as described previously (38). Unless 
otherwise indicated, all NMR samples were 1.5mM. NMR spectra were recorded at 25°C on 
a Bruker DRX500 spectrometer operating at a *H frequency of 499.867 MHz. Bovine calf 
thymus CypA (Sigma) was used for NMR experiments. 
In vitro kinase assays. Cell growth conditions, baculovirus infections, and the production of 
high titer baculovirus stocks were as previously described (39). Sf9 cells (obtained from 
American Type Culture Collection) were infected with baculovirus expressing Itk (gift from 
Leslie J. Berg). Harvested cells were lysed in 1% IGEPAL (Sigma) lysis buffer and lysates 
were cleared by centrifugation at 14,000 rpm for 15 minutes at 4°C. Itk was 
immunoprecipitated with anti-Itk antibody clone 2F12 (Upstate Biotechnology) and protein 
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G agarose (GibcoBRL) then washed three times in 50 mM Tris pH 7.6 wash buffer then 
washed once in kinase buffer (50 mM HEPES buffer pH 7, 10 mM MgCh, 10 mM MnCI,) 
before resuspension in ATP/kinase buffer (kinase buffer + 0.5 mM Na3V04, 0.5 mM ATP). 
Kinase reactions were stopped after 30 minutes by addition of 2x SDS loading dye and 
boiling samples. Samples were resolved on a 10% SDS-polyacrylamide gel, transferred to 
Immobilon-P membranes (Millipore) and Itk autophosphorylation was detected with anti-
phosphotyrosine antibody clone 4G10 (Upstate Biotechnology). Itk was detected with anti-
Itk antibody. The level of Itk phosphorylation was analyzed by normalizing detected 
phosphotyrosine to total Itk in each lane with NIH Image. Recombinant CypA (1 ^M, 
Sigma) and CsA (3 ^M, Sigma) were incubated for 6 hours with constant agitation at 4°C. 
The complex was then centrifuged at 14,000 rpm for 20 minutes to remove any precipitate. 
Assay of protein phosphorylation in Jurkat T cells. Jurkat clone E6-1 cells were obtained 
from ATCC. Cells were maintained at 37°C, 5% CO, in RPMI medium 1640 (GibcoBRL) 
supplemented with 10% fetal calf serum (HyClone) and lx penicillin-streptomycin-glutamine 
solution (GibcoBRL). 1.25 mg/mL stock solutions of CsA and FK-506 were prepared in 
DMSO. 2 x 107 Jurkat cells were incubated for 1 hour in the presence of 500 ng/mL of CsA, 
FK-506 (Calbiochem), or an equal volume of DMSO at 37°C, 5 % CO,. Before stimulation, 
the cells were washed twice with ice-cold media lacking fetal calf serum and lx penicillin-
streptomycin-glutamine solution containing CsA, FK-506, or DMSO and then resuspended 
in 400 nL of the same media. Stimulations were performed by incubating the cells on ice for 
20 minutes with 10 jig/ mL anti-CD3 antibody (PharMingen), quickly pelleting the cells, and 
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resuspending in 50 jig/ mL rabbit anti-mouse IgG (Sigma) at 37°C for the indicated times. 
Stimulations were stopped by diluting the cells 3-fold into ice-cold PBS resuspension buffer 
(phosphate buffered saline supplemented with 1 mM Na3V04 and 20 mM NaF). Cells were 
pelleted and resuspended in ice-cold RIPA lysis buffer, lysates were cleared by 
centri(ligation. Cleared lysates were depleted of remaining antibodies used during the 
stimulation by incubation with protein G agarose for 1 hour at 4°C with constant rocking. 
Either Itk, Zap-70 or PLCyl were immunoprecipitated from pre-cleared lysates with either 
anti-Itk antibody, anti-Zap-70 antibody (Upstate Biotechnology), or anti-PLCyl antibody 
clone B-6-4 (Upstate Biotechnology) and protein G or protein A agarose. 
Immunoprecipitates were washed 3 times in RIPA lysis buffer and once in PBS resuspension 
buffer. Samples were resolved on an 8% or a 12.5% (for CypA detection) SDS-
polyacrylamide gel. Itk detection was as described above and Zap-70 and PLCyl were 
detected with anti-Zap-70 antibody and anti-PLCyl antibody, respectively. CypA was 
detected with anti-CypA (Calbiochem), and FKBP12 was detected with anti-FKBP (N-19) 
(Santa Cruz Biotechnology, Inc.). The identity of the CypA band was confirmed by co-
migration with purified protein purchased from Sigma. 
Competitive binding assays. Lysates and immunoprecipitated Itk were obtained as 
described above from unstimulated Jurkat T cells. The protein G agarose, containing 
immunoprecipitated Itk, was briefly centrifuged and the supernatant was removed. The 
agarose was then resuspended in 100 jaL of RIPA cell lysis buffer that contained 50 pg of the 
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indicated ligand. After 1 hour of incubation at 4°C with constant rocking, the agarose was 
washed 3 times in RIPA lysis buffer and once in PBS resuspension buffer before 
resuspension in 20 p.L of 2x SDS loading dye. Samples were resolved on a 12.5% SDS-
polyacrylamide gel. Detection of CyP A and Itk were as described above. Itk GST-SH3 was 
detected with anti-GST (Upstate Biotechnology). The level of CypA co-
immunoprecipitation was analyzed by normalizing detected CypA to total Itk in each lane 
using NIH Image. Synthesis of the ADpYEPP and QQPPVPPQRPMA peptides was carried 
out by Gautam Sarath at the University of Nebraska Lincoln Protein Core Facility. 
Results 
Proline isomerization induces conformational heterogeneity within the Itk 
SH2 domain. Structural analysis of the purified Itk SH2 domain shows two well-defined, 
low energy conformations are populated in solution (Fig. la). NMR resonance assignments 
for the l5N-labeled Itk SH2 domain reveal two sets of resonances in slow exchange for 35 of 
the 109 SH2 residues. Characteristic NOE correlations (40) between Asn-286 and Pro-287 
indicate that proline cis/trans isomerization around the Asn-286-Pro-287 imide bond is the 
source of the conformational heterogeneity. A heteronuclear single quantum correlation 
(HSQC) (41) spectrum of the Itk SH2 domain in which Pro-287 is mutated to Gly (Fig. lb) 
confirmed this assessment. For the P287G mutant, in which the 286-287 amide bond adopts 
only the trans conformation, all of the 'H-I5N crosspeaks assigned to the cis conformer are 
absent. For many of the SH2 residues in the wild type protein, the differences in chemical 
95 
shift values between the cis and trans conformera are large (>6ppm in the l5N dimension and 
>lppm in the 'H dimension), reflecting significant differences in the chemical environment of 
nuclei in the two forms (Fig. la). The largest chemical shift differences between the cis and 
trans con formers occur for residues surrounding Pro-287 in primary amino acid sequence. 
However, it is notable that large chemical shift differences are also apparent in regions 
removed in primary sequence from Pro-287, in particular, residues located within the C-
terminus of the SH2 domain (residues 329-335). Together, the conformational^ 
heterogeneous regions map to a contiguous surface of the Itk SH2 domain (Fig. 2a,b). 
The cis and trans proline con formers bind different ligands. We have previously 
demonstrated that the Itk SH2 domain mediates two distinct binding events: canonical 
recognition of phosphotyrosine-containing peptides and phosphotyrosine-independent 
dimerization via contacts to the Src homology 3 (SH3) binding pocket of another Itk molecule 
(38). Chemical shift mapping reveals the contiguous SH2 surface residues that are involved in 
binding to either the Itk SH3 domain (Fig. 2a) or phosphopeptide (Fig. 2b). The overlap 
between the SH3 and phosphopeptide binding surfaces is within the conformational^ 
heterogeneous region of the Itk SH2 domain. This suggests that the conformational 
heterogeneity induced by proline isomerization plays a role in regulating ligand selection. 
Indeed, addition of excess Itk SH3 domain to the SH2 domain shifts the cis/trans equilibrium 
to favor the cis SH2 conformer (Fig. 2c). As well, shifts in the positions of crosspeaks 
corresponding to the cis proline conformer but not those of the trans SH2 conformer are 
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observed in the HSQC spectrum of the Itk SH2 domain to which recombinant Itk SH3 
domain has been added (Fig. 2d). Thus, the cis Asn-286-Pro-287 imide bond, and not the 
trans, is required for Itk dimerization. In contrast, a phosphotyrosine-containing peptide 
binds preferentially to the trans SH2 conformer. Addition of excess phosphopeptide to the 
Itk SH2 domain shifts the equilibrium to favor the trans conformer (Fig. 2e). Chemical shift 
changes are observed for crosspeaks corresponding to some residues in the trans SH2 
conformer but not for those same residues in the cis (Fig. 2f). This demonstrates conformer-
specific ligand recognition mediated entirely by isomerization of a single imide bond. 
The Itk SH2 domain is a substrate for the PPIase, CypA. NMR linewidths (42) 
were examined in spectra of l5N-labeled SH2 domain in the presence of substoichiometric 
amounts of two different PPIases (CypA and FKBP-12). Line-broadening of the 
conformationally heterogeneous resonances within the Itk SH2 domain was observed upon 
addition of 3 mol% and 20 mol% CypA (Fig. 3). In contrast, the spectrum of the Itk SH2 
domain incubated with 13 mol% FKBP-12 was identical to that of SH2 domain alone (data 
not shown). Addition of CypA to the Itk SH2 domain also caused small increases in all 
linewidths and specific chemical shift perturbations that were localized to residues 
surrounding Pro-287. The P287G mutation within the Itk SH2 domain abrogates interaction 
with CypA (data not shown). Together, these data provide evidence for a direct, specific, and 
productive interaction between CypA and a folded domain of a protein tyrosine kinase. By 
lowering the kinetic barrier to interconversion, CypA accelerates cis/trans isomerization and 
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may play an integral role in a coupled equilibrium system involving conformer-specific 
recognition (Fig. 3d). Such a mechanism would allow Itk to switch binding partners more 
rapidly in response to exogenous signaling events. 
CypA is an inhibitor of Itk kinase activity. Given the fact that CypA catalyzes 
the cis/trans isomerization within the Itk SH2 domain, we carried out in vitro functional 
assays to examine the role of CypA in regulating Itk activity. Itk was expressed in Sf9 cells 
with the baculovirus expression system and purified by immunoprecipitation. Following 
incubation with ATP, in vitro Itk autophosphorylation (39) was detected by Western 
blotting. Itk autophosphorylation was decreased significantly in the presence of CypA (Fig. 
4a). CsA reversed the effect of CypA on Itk kinase activity (Fig. 4a). Thus, CypA inhibits 
Itk kinase activity in vitro. 
To assess the role of cyclophilin in regulating Itk activity in vivo, the level of Itk 
phosphorylation was monitored following TCR/CD3-induced stimulation of Jurkat T cells 
that were either untreated or treated with CsA. Itk tyrosine phosphorylation, as monitored 
by Western blotting, was apparent at early timepoints following TCR stimulation. The level 
of Itk phosphorylation in untreated cells increased after a 40 second stimulation and then 
decreased toward basal levels after a 2 minute stimulation (Fig. 4b). In the CsA treated cells, 
the level of Itk phosphorylation was higher than the untreated cells at both timepoints (Fig. 
4b). Additionally, endogenous CypA was detected in Itk immunoprecipitates prepared from 
Jurkat T cells that have not been treated with CsA indicating the presence of a stable Itk-
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CypA complex in T cells (Fig. 4c). In Itk immunoprecipitates of cells pre-treated with CsA, 
the amount of CypA was less than in untreated cells (Fig. 4c). The effect of CypA on Itk 
phosphorylation is specific since FK-506 treatment of Jurkat cells had no detectable effect on 
Itk phosphorylation (Fig. 4d) and FKBP-12 was not detected in Itk immunoprecipitates of 
untreated cells or cells treated with FK-506 (data not shown). This observed specificity is 
consistent with NMR experiments that reveal that CypA, but not FKBP, affects the 
cis/trans isomerization within the Itk SH2 domain (Fig. 3). Since both CsA and FK-506 
treatment lead to inhibition of calcineurin and subsequent immunosuppression (29,30), the 
absence of an FK-506 mediated effect on Itk phosphorylation levels indicates that the 
increase in Itk phosphorylation upon treatment with CsA (Fig. 4b) is the direct result of 
inhibition of CypA activity and is not related to the immunosuppressive action of CsA. 
CsA treatment affects the phosphorylation state of PLCyl but not Zap-70 in 
Jurkat T cells. Phosphorylation of the upstream and downstream signaling partners of Itk, 
Zap-70 and PLCyl, respectively (43-45) was monitored following TCR/CD3-induced 
stimulation of Jurkat T cells carried out in the presence and absence of CsA. Zap-70 
phosphorylation levels at both 40 second and 2 minute stimulations are unchanged by 
treatment with CsA (Figure 4e) consistent with the placement of Zap-70 upstream of Itk. In 
contrast, an increase in the level of PLCyl phosphorylation in a manner that parallels Itk is 
observed following CsA treatment of Jurkat cells. PLCyl phosphorylation is higher after 
both the 40 second and 2 minute stimulations in CsA treated cells as compared to the same 
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timepoints from untreated cells (Fig. 4f). Therefore, Zap-70, a signaling molecule upstream 
of Itk is not affected by CsA treatment whereas, PLCyl, a signaling molecule downstream of 
Itk is up-regulated by CsA treatment. These data suggest that an increase in Itk activity 
resulting from inhibition of CypA leads to a concomitant increase in downstream PLCyl 
activity. 
The Itk SH2 domain mediates CypA binding in T cells. Competitive binding 
assays with ligands that specifically target the Itk SH2 domain provide evidence that the Itk-
CypA interaction in Jurkat T cells is mediated by the Itk SH2 domain. The presence of two 
different SH2 ligands in Itk immunoprecipitates from Jurkat T cells Itk SH3 domain (38) or 
the phosphopeptide (ADpYEPP, denoted pTyr)) decreased the amount of co-
immunoprecipitated CypA (Fig. 5, /'). In contrast, the presence of a peptide ligand that binds 
specifically to the Itk SH3 domain (QQPPVPPQRPMA, denoted PXXP) caused no 
detectable change in the amount of co-immunoprecipitated CypA (Fig. 5, /). Consistent with 
our previous structural analysis of Itk dimerization (38), a significant amount of Itk GST-
SH3 was detected following washing of Itk immunoprecipitates that have been incubated Itk 
GST-SH3 (Fig. 5, ///). This observation is consistent with the presence of the cis SH2 
conformer in full-length Itk from Jurkat T cells. Taken together, in vitro, in vivo and NMR 
data implicate CypA as a regulator of Itk activity in T cells and indicate that P287 within the 
Itk SH2 domain mediates critical regulatory interactions with CypA. 
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Discussion 
Our data suggest that displacement of CypA activates Itk. Phospholigand binding 
and Itk dimerization both compete with CypA binding to the Itk SH2 domain (Fig. 5). A 
mechanistic model for Itk activation (Fig. 6) can be proposed based on the well understood 
structural details of SH2-phospholigand recognition (46). The SH2 domain consists of two 
adjacent binding pockets: the 'pY' pocket that contacts the phosphotyrosine residue itself 
and the 'pY+3' pocket that confers ligand-binding specificity by contacting amino acids 
flanking the phosphotyrosine. Unlike the Itk pY+3 pocket, the pY binding site is not 
affected by proline-induced conformational heterogeneity (Fig. 2a,b), nor does it appear, 
based on the lack of chemical shift perturbations, to be sterically occluded by CypA binding. 
Itk activation by a phospholigand may therefore be initiated by binding of the 
phosphotyrosine itself to the accessible pY pocket in the SH2 domain. Subsequent pY+3 
engagement would displace CypA and stabilize the active, trans SH2 conformer (Fig. 6). In 
fact, phospholigand binding to the SH2 domain has previously been shown to activate Itk 
(45,47). Our data indicate that Itk dimerization also causes displacement of CypA (Fig. 5) 
but results in stabilization of the cis SH2 conformer for which functional data have not yet 
been obtained. Nevertheless, the activity of Itk appears to correlate with the identity of SH2 
bound ligand and therefore the configuration of the Asn-286-Pro-287 imide bond. 
At this time, the relative affinities of the Itk-CypA interaction, SH3/SH2 mediated Itk 
dimerization, and Itk SH2-phospholigand binding in a cellular context are not known. 
Certainly, the presence of CypA in immunoprecipitates of Itk suggests that it is a stable 
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binding partner of Itk in T cells. NMR data show that CypA binds to the Itk SH2 domain 
and catalyzes the cis/trans isomerization of the N286-P287 imide bond. These two 
observations suggest two possible modes of action in vivo. CypA (as a binding partner) may 
act as a repressor of Itk activity by stabilizing a transition-state conformation (48) around the 
N286-P287 imide bond within Itk (Fig. 6). Alternatively, CypA (as a catalyst) may facilitate 
rapid interconversion between the trans and cis Itk con formers and therefore between the 
phospholigand bound and dimerized states, respectively (Fig. 3d). In any case, structural 
rearrangements in the SH2 domain due to dimerization, CypA or phospholigand binding 
could allosterically regulate the neighboring kinase domain, in a manner analogous to the 
established conformational regulation of the Src kinases (2,3). The specific interactions 
mediated by the regulatory domains in the Tec family kinases are different from the Src 
family kinases, yet the ability of these domains to control the catalytic activity through 
conformational changes in the kinase domain may be similar. 
To date, detailed mechanistic studies of PPIase function have been limited to analysis 
of peptidyl-prolyl isomerization within small peptide model systems. We have identified a 
folded protein target for CypA that provides the opportunity to study the PPIase catalytic 
mechanism in the context of a physiological protein substrate. An analysis of the extent to 
which the tertiary structure of a physiological substrate affects CypA activity is now 
tractable and comparison with structures such as the CypA-HIV capsid protein complex (49) 
should shed additional light on the mode of action of CypA. Moreover, the past decade has 
witnessed an enormous effort to elucidate the mode of action of the immunosuppressive 
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agents, CsA and FK-506. This work has advanced our understanding of T cell signaling and 
our ability to control the immune response. While these natural products target the active 
sites of cyclophilin and FKBP, the fact that they inhibit PPIase activity is apparently 
irrelevant to their immunosuppressive effects. The discovery of a non-receptor protein 
tyrosine kinase as a physiological target of CypA in T cells raises the possibility that other 
conformationally heterogeneous kinases exist that are regulated by PPIases in a similar 
manner. These findings are provocative in light of the high incidence of cancer that 
accompanies the use of CsA in organ transplant patients (50). Hyperactivation of protein 
tyrosine kinases, including Itk, during clinical use of PPIase inhibitors may contribute to 
unregulated cellular proliferation and ultimately formation of malignancies in 
immunosuppressed patients. Certainly, further exploration of the physiological roles of the 
PPIases is warranted and may provide a framework upon which more selective 
immunosuppressive therapies may be developed. 
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Fig. 1. The Itk SH2 domain adopts two stable structures in solution, (a) 'H-I5N HSQC 
spectrum of purified, recombinant L5N-labeled Itk SH2 domain. The resonances 
corresponding to the cis (c) and trans (/) con formers are connected by a gray double-headed 
arrow. The inset is an expansion of the boxed region of the spectrum containing 
representative doubled resonances for the Asn-325 side chain (se) NH, and the Lys-258 
backbone NH. (b) HSQC spectrum of the Itk SH2 domain in which Pro-287 is mutated to 
Gly. Labeled crosspeaks correspond to those that are labeled in (a) and the crosspeak 
corresponding to Gly-287 (introduced by mutation) is assigned. Inset is the same region as in 
(a) but shows a single resonance for Asn-325(sc) and Lys-258. 
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Fig. 2. Surface representations (rendered with MolMol (51 )) of the Itk SH2 cis (a) and trans 
(b) structural models (R.J.M. and A.H.A., unpublished results). The SH2 residues that 
display conformational heterogeneity are demarcated with a dotted line on each model. Pro-
287 is indicated and the pY and pY+3 binding pockets are labeled. Chemical shift 
perturbations that occur upon addition of equimolar Itk SH3 domain to the Itk SH2 domain 
(38) are mapped onto the cis model and highlighted in gray (a). Likewise, SH2 residues that 
undergo chemical shift perturbations upon addition of three times excess phosphopeptide 
(ADpYEPPPSNDE) are highlighted in yellow on the trans model (b). For both surface 
models, residues that do not exhibit chemical shift changes upon addition of ligand are 
orange, (c) Select region of the HSQC spectrum of a 0.5mM Itk SH2 sample left, Itk SH2 
domain alone where the trans/cis ratio is approximately 60:40 based on the crosspeak 
volumes for each set of doubled resonances, right, The same region of the Itk SH2 HSQC 
spectrum after addition of 10 times excess unlabeled Itk SH3 domain (trans/cis ratio 10:90). 
(d) Superposition of the same region of two HSQC spectra of l5N-labeled Itk SH2 domain in 
the absence (black) and presence (gray) of unlabeled Itk SH3 domain. The Thr-331 cis 
crosspeak shifts upon addition of equimolar Itk SH3 domain (arrow) while the Thr-331 trans 
crosspeak remains at the same frequency, (e) left, Itk SH2 domain (trans/cis 60:40) right, 
Addition of 3 times excess phosphopeptide to Itk SH2 (trans/cis 90:10). (f) Superposition of 
two HSQC spectra of l5N-labeled Itk SH2 domain in the absence (black) and presence (gray) 
of 3 times excess phosphopeptide. The Ala-261 and Ala-281 trans crosspeaks shift upon 
addition of phosphopeptide (arrows) while the Ala-261 and Ala-281 cis crosspeaks resonate 
at the same frequency regardless of ligand present. (The Ala-281 cis crosspeak is shown in 
the inset due to the large difference in resonance frequencies for the cis and trans resonances 
of Ala-281.) 
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Fig. 3. (a) Region of the HSQC spectrum for the l5N-labeled Itk SH2 domain (0.5 mM) that 
includes crosspeaks for the Gln-320, His-322 and Val-330 backbone NH resonances. Gln-
320 and His-322 are not affected by cis/trans isomerization around the Asn-286-Pro-287 
imide bond and therefore each appears as a single crosspeak. In contrast, the Val-330 amide 
resonance is doubled as a result of slow exchange between the cis and trans forms, (b) Same 
region of the HSQC spectrum for the Itk SH2 domain (0.5 mM) in the presence of 3 mol% 
CypA. Line broadening is apparent for all of the doubled resonances in the SH2 domain 
spectrum upon addition of CypA, while those peaks that correspond to residues unaffected by 
the isomerization event do not broaden significantly, (c) Addition of 20 mol% CypA to the 
Itk SH2 domain results in further line broadening and coalescence to the chemical shift value 
that represents the average of the cis and trans conformers. One-dimensional projections 
through the center of the Val-330 crosspeaks along the 'H axis illustrate the exchange 
mediated broadening and coalescence, (d) Equilibrium model encompassing the CypA 
catalyzed Itk SH2 cis/trans interconversion, cis mediated SH3 binding (Itk dimerization) and 
trans mediated phospholigand (pY) binding. 
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Fig. 4. (a) CypA, CypA/CsA complex, or CsA were added to baculovirus expressed Itk 
immediately prior to resuspension in ATP/kinase buffer. A mock kinase assay of Itk (left 
lane) was performed in which ATP was excluded from the kinase reaction buffer. Itk 
phosphorylation is normalized to Itk protein levels and net changes in phosphorylation are 
indicated below each lane. For (b) through (f) lanes 1, 2 and 3 are mock stimulation, 40 
seconds and 2 minutes, respectively, following TCR stimulation of Jurkat cells in the absence 
(-) of drug treatment while lanes 4, 5 and 6 represent the same conditions in the presence (+) 
of drug, (b) Itk phosphorylation following TCR stimulation of Jurkat cells in the presence 
and absence of CsA. (c) CypA binding to Itk was monitored by detection of Itk 
immunoprecipitates with an anti-CypA antibody, (d) Itk phosphorylation in the presence and 
absence of FK-506. (e) Zap-70 phosphorylation and (f) PLCyl phosphorylation in the 
presence and absence of CsA. Phosphorylation levels of Itk, Zap-70 and PLCyl are 
normalized to total protein in each lane. Net changes in phosphorylation relative to 
phosphorylation levels at 40 seconds following stimulation in the absence of drug (lane 2) 
are indicated below each lane. 
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Fig. 5. For the indicated samples, GST, Itk GST-SH3, phosphotyrosine-containing peptide 
(pTyr), or a proline-rich peptide (PXXP) were incubated with full-length Itk following 
immunoprecipitation from Jurkat T-cell lysates. Following extensive washing, the amount of 
CypA that co-immunoprecipitated with Itk was determined by immunoblotting {Top, /). The 
amount of CypA in Itk immunoprecipitates is normalized to total Itk in each lane. Net 
changes in the amount of co-immunoprecipitated CypA relative to the amount that co-
immunoprecipitates with Itk in the absence of exogenous factors are indicated. {Bottom, iii) 
Detection of GST-SH3 in Itk immunoprecipitates following competitive binding assay. 
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Fig. 6. Model for Itk regulation. Itk is dark gray and includes the proline-rich region, SH3, 
SH2 and kinase domains (the PH domain and part of the TH domain are not shown for 
clarity). Two 'states' of Itk are depicted: inactive, CypA-bound Itk and active, 
phospholigand-bound Itk. CypA is light gray and is shown bound to the Itk SH2 domain in 
the region of Pro-287. The proposed configuration of the Asn-286-Pro-287 imide bond 
(resembling the transition state for cis/trans interconversion) is illustrated for the inactive, 
CypA bound form of Itk. NMR spectroscopic data suggest that cyclophilin-bound Itk is 
monomenc (unpublished results, K.N.B. & A H A.) and the proline-rich region may contact 
the SH3 binding pocket in an intramolecular fashion (52). Activation may be accompanied 
by phosphorylation of Y180 in the SH3 domain expelling bound proline (53). Cis/trans 
isomerization around Asn-286-Pro-287 causes pronounced conformational heterogeneity in 
the C-terminus of the Itk SH2 domain leading directly into the Itk kinase domain (see Fig. 1). 
The C-terminus of the Itk SH2 domain may adopt a conformation in the presence of 
cyclophilin that structurally perturbs the kinase catalytic site rendering it inactive. Release of 
cyclophilin, either by Itk dimerization to favor the cis conformer (not shown) or by binding 
of a phosphotyrosine-containing ligand to favor the trans conformer may lead to 
reorganization of the C-terminal SH2 residues and subsequent restructuring of the kinase 
active site. 
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CHAPTER 4. Proline cis/trans isomerization governs the quaternary 
structure of the T cell specific tyrosine kinase Itk 
A paper submitted to the Journal of Molecular Biology (2002). 
Kristine N. Brazin, D. Bruce Fulton and Amy H. Andreotti 
Summary 
We have examined the role of proline cis/trans isomerization in determining the 
quaternary structure of the T-cell specific tyrosine kinase, Interleukin-2 tyrosine kinase (Itk). 
Two distinct structural arrangements have been previously described for the non-catalytic 
domains of Itk. An intermolecular self-association mediated by a specific interaction between 
the Itk Src homology 2 (SH2) and Src homology 3 (SH3) domains results in dimerization of 
SH2- and SH3-containing fragments. As well, the structure of an intramolecular complex 
between the SH3 domain and the adjacent proline-rich stretch within Itk has been solved 
previously. Both intermolecular SH2 binding and intramolecular binding of the Itk proline-
rich region require the conserved binding pocket of the Itk SH3 domain and are therefore 
mutually exclusive. We now demonstrate that cis/trans isomerization around the imide bond 
preceding the proline residue at position 287 (P287) in the Itk SH2 domain determines which 
ligand binds to the adjacent SH3 domain. The cis conformation of the prolyl 287 imide bond 
is required for intermolecular contacts to an opposing SH3 domain and therefore Itk dimer 
formation. Mutation of the conformationally heterogeneous P287 to a glycine results in 
formation of the previously described intramolecular interaction between the SH3 domain and 
1 2 1  
the proline-rich region. Thus, proline isomerization serves as a molecular switch that 
regulates the quaternary structure of Itk. 
Introduction 
Inspection of the domain structure of protein kinases reveals the presence of non-
catalytic domains outside of the catalytic core. In particular, SH2 and SH3 domains are 
adjacent to the catalytic domain in numerous kinases.1,2 For the Src family of tyrosine 
kinases, x-ray crystallographic analyses have clearly defined the role of these non-catalytic 
domains in controlling kinase activity.3,4,5 An intramolecular interaction between the SH3 
domain and the linker sequence preceding the kinase domain as well as an intramolecular 
contact between the Src SH2 domain and a phosphorylated tyrosine in the carboxy-terminal 
tail are critical for inhibition of Src catalytic activity. Mutation or deletion of the non-
catalytic regulatory domains of Src leads to constitutive activity that in a cellular context 
promotes aberrant cellular signaling and results in uncontrolled cell growth.6,7,8 The second 
largest class of SH3 and SH2-containing tyrosine kinases, the Tec family kinases, modulate 
hematopeotic cellular responses to external stimuli.9,10 The Tec kinases share sequence 
homology with the Src kinases in the region that spans the SH3, SH2 and kinase domains but 
contain two distinct, defining domains (Pleckstrin homology (PH) and Tec homology (TH)) 
and lack the carboxy-terminal regulatory sequence critical to Src regulation. The regulatory 
mechanisms of the Tec family kinases are not known. However, differences in the domain 
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structures between the Src and Tec kinases demand distinct mechanisms of regulation for the 
Tec family. 
The T cell specific Tec family member, Interleukin-2 tyrosine kinase (Itk),111213 is an 
important component of antigen receptor signaling pathways.14,15,16 To date, structural 
characterization of Itk has been limited to two different Itk fragments. First, structure 
determination using nuclear magnetic resonance (NMR) spectroscopy revealed an 
intramolecular interaction between the binding cleft of the Itk SH3 domain and the adjacent 
proline-rich region of the Itk TH domain.17 This structure represents the first 
characterization of an m/ramolecular SH3 mediated binding event and is proposed to serve a 
regulatory role in Itk substrate recognition and function. We have more recently characterized 
an m/ermolecular association between the conserved binding cleft of the Itk SH3 domain and 
the Itk SH2 domain and have shown that these contacts mediate dimerization of the dual SH3 
and SH2 domain-containing fragment of Itk (SH3-SH2).18 Thus, the same conserved SH3 
binding pocket within Itk is required for both intramolecular proline recognition and 
intermolecular association with the SH2 domain to form dimer. 
These previously characterized conformational states of Itk are mutually exclusive 
and therefore raise questions about the structure of the region surrounding the SH3 domain in 
full length Itk. To elucidate the respective roles of these two conformational states, we have 
now examined a larger Itk fragment that contains the SH3 domain and both SH3 ligands: the 
proline-rich region of the TH domain and the SH2 domain. Our data indicate that for this 
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larger fragment of Itk, dimer predominates in solution and that the SH2 domain, and not the 
Itk proline-rich region, occupies the conserved SH3 binding pocket. 
Closer inspection of the SH3/SH2 mediated dimerization of Itk has revealed a 
requirement for a cis prolyl imide bond within the Itk SH2 domain.19 In fact, a single 
conformationally heterogenous proline residue at position 287 within the Itk SH2 domain 
mediates not only dimerization, but also phospholigand binding. The P287 trans 
conformation is stabilized by canonical phosphotyrosine ligand binding to the SH2 domain.19 
Furthermore, P287 is required for interaction of the Itk SH2 domain with the peptidyl prolyl 
isomerase, cyclophilin A, which we have shown regulates Itk catalytic activity both in vitro 
and in Jurkat T cells.'9 We now report that the conformational state of P287 within the SH2 
domain also controls ligand binding to the adjacent SH3 domain. Mutation of the 
conformationally heterogeneous proline to glycine, stabilizing the SH2 domain in the trans 
conformation, eliminates Itk dimerization and promotes formation of the z>7/ramolecular 
proline-SH3 interaction. Thus, cellular signaling events that alter the conformational state of 
P287 within the Itk SH2 domain (phospholigand, cyclophilin A binding or Itk dimerization) 
may all influence the nature of Itk self-association and therefore regulate the interactions of 
Itk with endogenous signaling partners in the cell. 
Results 
Intermolecular SH3/SH2 interaction out-competes intramolecular proline binding to 
the SH3 domain 
124 
Using NMR spectroscopy, we examined the extent to which Itk SH3/SH2 mediated 
dimerization competes with formation of the intramolecular proline-SH3 complex. A 
uniformly l5N-labeled fragment of Itk containing the proline-rich region (Pr), SH3, and SH2 
domains (denoted Pr-SH3-SH2) was expressed in bacteria and purified (Figure la). The 
heteronuclear single quantum coherence (HSQC) spectrum of Pr-SH3-SH2 was compared to 
that previously reported for the SH3-SH2 dimer18 (Figure lb & c, panels i & //) and that of 
the Pr-SH3 fragment (Figure lb & c, panel ///). For residues within the SH3 binding pocket 
(representative crosspeaks for W208 and S224 are shown in Figures lb & c, respectively), 
the Pr-SH3-SH2 resonance positions are similar to those of SH3-SH2 but are quite dissimilar 
to those of Pr-SH3. These data suggest that for Itk Pr-SH3-SH2, the chemical environment 
of residues in the SH3 binding pocket is similar to that of the previously characterized SH3-
SH2 fragment. 
To fully assess the chemical environment of the entire SH3 domain in the larger Itk 
constructs, we compared the chemical shift values of the isolated Itk SH3 domain with SH3 
domain resonances in the context of larger Itk fragments (SH3-SH2, Pr-SH3-SH2 & Pr-SH3). 
The 'H and l5N chemical shift differences between the isolated SH3 domain and the larger 
fragments (A§x = 8 SH3 - $ x> where X= SH3-SH2, Pr-SH3-SH2 or Pr-SH3) are plotted for 
each SH3 residue in Figure 2. First, in all cases, the observed chemical shift changes map to 
the conserved binding pocket of the SH3 domain (Figure 3) in agreement with previous 
structural work.17,18 The magnitude and direction of the values of AÔ for Itk SH3-SH2 and 
Pr-SH3-SH2 are similar (compare Figure 2a&b) yet show distinct differences when compared 
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to the AÔ values measured for Itk Pr-SH3 (Figure 2c). For example, in addition to the 
chemical shift perturbations illustrated in Figure lb & c, HSQC crosspeaks corresponding to 
Y182 and E228 in the Itk SH3-SH2 and Pr-SH3-SH2 constructs show large shifts with 
respect to Itk SH3 alone but no change in resonance frequency upon intramolecular proline 
association. In contrast, the l5N resonance of R193 shifts significantly down field upon 
intramolecular proline binding but changes minimally upon dimer formation. 
Analysis of the SH2 resonances within Itk Pr-SH3-SH2 fragment provides additional 
evidence for the presence of the SH3/SH2 intermolecular interaction within Pr-SH3-SH2. 
Chemical shift perturbations for the SH2 domain in the context of Pr-SH3-SH2 are similar in 
magnitude and direction to those previously described18 for the shorter Itk SH3-SH2 fragment 
(data not shown). Chemical shift perturbations observed for both the SH3 and SH2 domains 
therefore indicate that the SH3 binding pocket in the context of Pr-SH3-SH2 is occupied by 
the previously defined surface of the SH2 domain.18 Thus, while both z'w/ermolecular and 
z>7/ramolecular self-association events are possible for the Pr-SH3-SH2 fragment of Itk, the 
SH3/SH2 intermolecular interaction predominates and formation of the intramolecular 
proline-SH3 complex is negligible. 
Intramolecular proline-SH3 interaction occurs in a Pr-SH3-SH2 mutant that does not 
form dimer 
While the purified Pr-SH3-SH2 fragment of Itk preferentially dimerizes in solution in 
a manner similar to the SH3-SH2 fragment, the /«rramolecular proline-SH3 interaction may in 
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fact be present in full length Itk and play a regulatory role under conditions that disfavor 
dimer. To eliminate dimerization in vitro, we constructed a mutant of Pr-SH3-SH2 in which 
the proline at position 287 within the SH2 domain is replaced with glycine (denoted Pr-SH3-
SH2*, Figure la). The amide bond preceding G287 will adopt only the trans conformation. 
The HSQC spectrum of Pr-SH3-SH2* (Figure lb & c, panel iv) was compared to that of Pr-
SH3 (Figure lb & c, panel ///), and to the HSQC spectrum of wild type Pr-SH3-SH2, for 
which dimer predominates (Figure lb & c, panel /). For both the Ser224 backbone amide 
resonance and the W208 indole NH resonance, Pr-SH3-SH2* is identical to that of Pr-SH3 
and not wild type Pr-SH3-SH2. 
A more comprehensive analysis reveals that the AÔ values for all of the SH3 
resonances in the context of Pr-SH3-SH2* are nearly identical to those of Pr-SH3 (Figure 2d). 
The observed chemical shift perturbations indicate that 1) the SH3 binding pocket within Pr-
SH3-SH2* is occupied by ligand (Figure 3b) and 2) the residues of the SH3 domain in the 
shorter Pr-SH3 fragment and the mutant Pr-SH3-SH2* are in a similar chemical environment. 
Thus, for the Pr-SH3-SH2 fragment, mutation of P287 in the Itk SH2 domain to glycine 
results in formation of the previously characterized intramolecular proline-SH3 interaction. 
Moreover, a comparison of HSQC spectra of SH2 in the context of the Pr-SH3-SH2* 
fragment and the isolated Itk SH2 domain mutant bearing the same P287G mutation reveals 
no chemical shift differences (data not shown). Therefore, unlike Pr-SH3-SH2, the SH2 
domain in the Pr-SH3-SH2* fragment is not involved in interactions that result in the 
chemical shift perturbations observed for the SH3 domain. Thus, for Pr-SH3-SH2*, 
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dimerization is abrogated and the proline-rich region contacts the SH3 domain in a manner 
indistinguishable from that of the Pr-SH3 fragment. 
Further biophysical analysis of Itk Pr-SH3-SH2 
NMR linewidths and self-diffusion coefficients (Ds)20 are two independent means to 
characterize the aggregation state of a molecular species in solution. Linewidths were 
measured for the Pr-SH3-SH2 and SH3-SH2 fragments at sample concentrations of 1.2 mM. 
*H NMR linewidths for Itk Pr-SH3-SH2 and SH3-SH2 are similar and range from 26-43 Hz 
and 28-33 Hz, respectively. A monomelic mutant of Itk SH3-SH2 (SH3*-SH2, where W208 
in the SH3 binding pocket is mutated to lysine) exhibits linewidths in the NMR spectrum 
that range from 19 to 25 Hz. In addition, NMR linewidths for Pr-SH3-SH2* range from 18-
23 Hz, consistent with a monomeric species. Thus, the broader lines observed for both SH3-
SH2 and Pr-SH3-SH2 indicate that both fragments self-associate to form higher molecular 
weight species in solution. NMR diffusion experiments were used previously to determine 
that the Itk SH3-SH2 fragment is involved in a monomer-dimer equilibrium.18 The self-
diffusion coefficient for Pr-SH3-SH2 (Ds=6.78±0.07x 10"7cm2/s) corresponds to that reported 
previously for SH3-SH2 (Ds=6.81 ±0.07x 10"7cm2/s) providing additional evidence that Pr-
SH3-SH2 dimerizes in solution in a fashion similar to that of SH3-SH2 (Figure 4). Together, 
chemical shift perturbations, NMR linewidths and diffusion data all support a dimeric 
structure for Pr-SH3-SH2 where the SH3 binding pocket is occupied by the SH2 domain 
across the dimer interface. Mutation of the conformationally heterogeneous P287 abrogates 
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dimerization and permits intramolecular contacts between the proline-rich region and the Itk 
SH3 domain. 
Monomer/dimer equilibrium of Itk Pr-SH3-SH2 fragment is shifted toward dimer 
compared to SH3-SH2 
It is notable that the magnitude of the observed chemical shift perturbations and the 
measured linewidths associated with the Pr-SH3-SH2 fragment are generally larger than those 
observed for the same fragment lacking the proline-rich region (Itk SH3-SH2). Given the fact 
that the monomer and dimer species are in fast exchange, the resonance frequency and 
linewidth of each SH3 residue is a weighted average of the frequencies and linewidths 
associated with the dimeric and monomelic species.21 Thus, extent of chemical shift changes 
corresponds to extent of dimerization and suggests that the monomer-dimer equilibrium for 
Itk Pr-SH3-SH2 is shifted toward dimer to a greater extent than the shorter SH3-SH2 
fragment. 
To test the extent to which each Itk fragment dimerizes, we monitored chemical shift 
perturbations during competitive binding assays with isolated SH3 and SH2 domains. We 
reasoned that the accessibility of both the SH3 and SH2 domains that comprise SH3-SH2 and 
Pr-SH3-SH2 should be limited by dimerization of these multidomain-containing Itk 
fragments. This competing equilibrium should therefore limit interaction with exogenous, 
singly expressed SH2 or SH3 domains (Figure 5a). In an HSQC spectrum of 15N-labeled SH3 
domain, extensive shifts are observed in a subset of SH3 resonances upon addition of 
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unlabeled Itk SH2 (Figure 5b). For these same residues, smaller shifts are observed upon 
addition of unlabeled Itk SH3-SH2 to l5N-labeied SH3 domain (Figure 5b). Dimerization of 
Itk SH3-SH2 occludes the SH2 binding surface and restricts binding of the isolated l5N-
labeled SH3 domain. The resonance frequencies for residues of the l5N-labeled SH3 domain 
are even closer to those of unbound SH3 domain upon addition of unlabeled Itk Pr-SH3-SH2 
(Figure 5b). These data are consistent with increased extent of dimerization for the larger Pr-
SH3-SH2 fragment that results in a decrease in the accessibility of the SH2 binding surface 
and a concomitant decreased interaction of Pr-SH3-SH2 with isolated l5N-labeled SH3 
domain. A parallel analysis using l5N-labeled Itk SH2 domain mixed with the various multi-
domain fragments yields the same result (Figure 5c). The accessibility of both the SH3 
binding pocket and the SH2 binding surface to exogenous ligands decreases upon dimerization 
of the SH3-SH2 and Pr-SH3-SH2 fragments. Moreover, it appears that the amino-terminal 
extension of the Pr-SH3-SH2 fragment enhances Itk dimerization affinity. 
Btk SH2 domain lacks a conformationally heterogeneous proline residue and does not 
interact with the Btk SH3 domain 
Bruton's tyrosine kinase (Btk)22,23 is a member of the Tec kinase family. In analogy 
to Itk, an intramolecular interaction between the proline-rich region of Btk and the adjacent 
SH3 domain has been observed.24 To investigate the possibility that Btk self-associates via 
the intermolecular SH3/SH2 interaction described for Itk, we first analyzed the isolated Btk 
SH2 domain. While not strictly conserved in position, a proline residue is present in the CD 
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loop of the Btk SH2 domain, whereas proline is completely absent from the primary amino 
acid sequence of the other Tec kinases (Figure 6a). We examined the possibility that the Btk 
SH2 domain might adopt multiple conformations and tested the extent to which the Btk SH2 
domain binds to the Btk SH3 domain. The l5N-labeled Btk SH2 domain was expressed and 
purified and yielded an HSQC spectrum typical of a domain that adopts a single, well-defined 
conformation in solution (Figure 6b). The number of backbone and sidechain NH groups in 
the Btk SH2 domain (residues 272 to 378) matched the number of crosspeaks in the HSQC 
spectrum. In contrast to Itk, the Btk SH3 domain does not interact with the Btk SH2 domain 
(Figure 6c, //). We would predict, based on these results, that the larger Btk SH3-SH2 
fragment will not dimerize in solution in a manner similar to the corresponding fragment of 
Itk. Other studies of the Btk SH3-SH2 fragment, however, have indicated the presence of 
dimer in solution.25 Dimerization of Btk SH3-SH2 in that case was attributed to formation of 
a disulfide bond between two Btk SH2 domains and not to an interaction between the Btk 
SH3 and SH2 domain. In our current study, we see no evidence for dimerization of the Btk 
SH2 domain (Figure 6b). Finally, we have observed that the conformationally heterogeneous 
Itk SH2 domain does not interact with the Btk SH3 domain despite sequence similarity 
between the Itk and Btk SH3 domains (Figure 6c, /'/'/). Thus, potentially important structural 
differences exist among the Tec family kinases; proline cis/trans isomerization, and therefore 
the cis dependent dimerization mechanism, may be unique to Itk. 
1 3 1  
Discussion 
Structural correlations between SH2 and SH3 domains have been previously reported 
for several tyrosine kinases. The linker sequence between the SH3 and SH2 domains of the 
Src kinase appears to mediate cross-domain communication in response to phosphorylation 
of the Src carboxy-terminal tail.26 In addition, hydrogen exchange studies indicate that SH3 
and SH2 domain dynamics differ when expressed alone or as part of larger, multi-domain 
containing protein fragments.27 We have not yet explored the effect of Itk proline cis/trans 
isomerization on the molecular dynamics of the adjacent SH3 domain, but instead have 
characterized a dynamic conformational switch within the SH2 domain that dictates ligand 
recognition and accessibility of the neighboring SH3 domain. Whether molecular motions or 
molecular recognition are coupled phenomena, the fact that SH3 and SH2 domains are often 
consecutive in primary amino acid sequence may be an important factor in the control of 
cellular signaling specificity. 
We have now determined that proline cis/trans isomerization within the Itk SH2 
domain governs the nature of SH3-mediated Itk self-association. The cis prolyl imide bond at 
position 287 within the Itk SH2 domain is required for dimerization through m/ermolecular 
contacts to an opposing SH3 binding pocket (Figure 7a).19 For the trans conformation of this 
peptide bond, dimerization is abrogated and the adjacent SH3 binding pocket is occupied in 
an zrt/ramolecular fashion by the proline-rich region of the TH domain (Figure 7b). Thus, 
cis/trans isomerization around the P287 imide bond within the Itk SH2 domain serves as a 
molecular switch that controls ligand occupancy of the adjacent SH3 domain and therefore the 
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quaternary structure of Itk. In multi-domain containing fragments of Itk in which competing 
equilibria between intra- and intermolecular self-association is possible, intermolecular self-
association appears to be favored over the intramolecular proline-SH3 interaction. 
Our data now clarify the interpretation of biochemical data that was reported with the 
structure of the intramolecular Itk proline-SH3 complex.17 In that report, binding of an SH3 
ligand, Sam-68, to a panel of recombinant SH3-containing Itk fragments was assayed by 
immunoblotting. First, it was observed that for Itk constructs containing only the SH3 
domain and the adjacent proline-rich region, Sam-68 out-competed the intramolecular proline-
SH3 interaction and associated directly with the Itk SH3 domain. In complete agreement 
with data presented here in Figure 5, the accessibility of the Itk SH3 binding pocket 
diminished significantly for larger Itk constructs containing the proline-rich region, the SH3 
domain and the SH2 domain. In fact, Itk fragments spanning the TH domain through the SH2 
domain (TH-Pr-SH3-SH2) did not associate with Sam-68 to a detectable level. Given the lack 
of knowledge regarding the SH3/SH2 mediated dimerization of Itk at the time, these data were 
interpreted to indicate that the /mramolecular interaction between the SH3 domain and the 
proline-rich region is stabilized by the presence of the SH2 domain.17 Our current data now 
reveal that reduced accessibility of the Itk SH3 domain in multi-domain containing constructs 
is the result of dimerization and not a stable intramolecular proline-SH3 interaction. 
It is interesting to note that the affinity of the SH3/SH2 mediated dimerization 
appears to increase in the Pr-SH3-SH2 fragment. This is perhaps unexpected given that 
direct competition for the SH3 binding pocket between the intramolecular proline ligand and 
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intermolecular SH2 binding should lead to a decrease in the affinity of dimerization. One 
possible explanation for the observed increase in affinity is that the proline-rich region is 
actively involved in stabilizing dimer, either by stabilizing the cis SH2 conformer or by direct 
contacts across the dimer interface. In fact, we have observed chemical shift perturbations for 
a subset of SH2 resonances in the Pr-SH3-SH2 fragment that are not observed in the SH3-
SH2 fragment (unpublished results, K.N.B & A.H.A.). These preliminary data indicate that, 
like the Itk SH3 domain, the proline-rich region may serve dual structural roles depending on 
the quaternary structure of Itk. 
The significance of the different quaternary structures of Itk in T cell signaling remains 
elusive. We have recently reported a direct regulatory interaction between the Itk SH2 
domain and the peptidyl prolyl isomerase, cyclophilin A.19 The cyclophilin A-Itk interaction 
requires P287 in the Itk SH2 domain, maps to the surface of the SH2 domain required for Itk 
dimerization, and inhibits Itk catalytic activity.19 We therefore predict that dimerization will 
be prevented in the inactive, cyclophilin A-bound state of Itk. The P287G mutant described 
here therefore serves as a model for the proposed monomelic, down-regulated form of Itk. 
Importantly, impedance of Itk dimerization in this mutant leads to formation of the 
m/romolecular interaction between the SH3 binding pocket and the adjacent proline-rich 
ligand of the TH domain. Thus, in the context of the inactive Itk kinase, the intramolecular 
proline-SH3 interaction may play an important regulatory role in limiting the ability of the 
Itk SH3 domain to interact with exogenous signaling partners. Itk dimerization may be a 
mechanism by which Itk is activated. Itk dimerization through SH3/SH2 mediated 
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interactions would facilitate displacement of cyclophilin from the Itk SH2 domain and 
removal of the proline-rich region from the SH3 binding pocket. Whether the dimer is 
retained in fully active Itk kinase or whether subsequent activation steps lead to dissociation 
of the dimer remains a question. Nevertheless, each of the quaternary structures of Itk 
appears to be associated with a discrete conformation around the imide bond preceding P287. 
Certainly, the conformational switch afforded by proline cis/trans isomerization within Itk is 
an important component of the Itk regulatory apparatus. 
The observation that the Btk SH2 domain does not exhibit conformational 
heterogeneity, combined with the absence of a direct Btk SH3/SH2 interaction, indicates that 
the apparently closely related Tec kinases differ significantly at a structural level and 
therefore in the mechanisms that control ligand recognition and catalytic activity.28 Previous 
structural work on the Btk and Tec kinases has revealed a propensity for dimerization 
through canonical proline-SH3 interactions instead of the SH3/SH2 intermolecular interaction 
discussed here for Itk.24,29,30 Dimerization of the Tec kinases may therefore serve a 
regulatory role in general, yet the molecular details of the dimer interface for each of the Tec 
kinases may differ dramatically. The observation that the cis Itk SH2 surface is recognized 
by the Itk SH3 domain and not the SH3 domain of Btk is noteworthy (Figure 5). The Itk and 
Btk SH3 domains are 52% identical and differ at 7 of the 20 residues at the SH3-SH2 dimer 
interface. Some of the amino acid differences in the Itk and Btk SH3 binding pockets may be 
significant in terms of steric and electrostatic contributions to ligand recognition. For 
example, the alanine at position 221 in Itk corresponds to isoleucine in Btk, Cysl94 and 
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Glu205 in Itk correspond to lysine and asparagine, respectively, in the Btk sequence. Thus, 
the specificity of the Itk SH3/SH2 interaction must involve unique structural features of both 
the SH3 and SH2 domains. The precise nature of the specificity-determining elements for 
this interaction and the role of dimerization and proline isomerization in regulating Tec family 
signaling will be clarified as additional structural and biochemical work is completed. 
Materials and Methods 
Protein expression and NMR Spectroscopy. 
Full-length Itk and Btk cDNA used for PGR amplification were gifts from Leslie J. Berg 
(University of Massachusetts Medical School) and Xin-Yun Huang (Cornell University 
Medical College), respectively. Domain boundaries for the multi-domain-containing Itk 
constructs are as follows (amino acid numbering corresponds to full length Itk": Itk Pr-SH3 
(154-232), Pr-SH3-SH2 and Pr-SH3-SH2* (154-338), SH3-SH2 and SH3*-SH2(W208K) 
(171-338). Protein samples used in these NMR studies were expressed and purified as 
described previously.18 Due to low levels of soluble expressed protein, the Itk Pr-SH3-SH2* 
mutant was extracted from inclusion bodies using 1.5% sarcosyl (Fisher). Subsequent 
purification steps remained the same although it should be noted that the Pr-SH3-SH2* 
mutant was less stable following purification. The sample precipitated before more extensive 
characterization (such as NMR diffusion experiments) could be carried out. All NMR 
spectra were recorded at 25°C on a Bruker DRX500 spectrometer operating at a *H 
frequency of 499.867 MHz. A gradient-enhanced HSQC experiment with minimal water 
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saturation was used for all 'H-I5N correlation experiments.31 The self-diffusion coefficient Ds 
for the Itk Pr-SH3-SH2 fragment was measured as described previously18 by use of a 
longitudinal encode-decode (LED) gradient experiment.20,32 
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Figure 1. (a) Domain structure of Itk and the corresponding SH3-containing fragments (Pr-
SH3-SH2, SH3-SH2, Pr-SH3, SH3, and Pr-SH3-SH2*). The proline-rich region (Pr) is part 
of the TH domain and is indicated by a small rectangle N-terminal to the SH3 domain. The 
relative positions of W208 and S224 in the SH3 domain and P287 in the SH2 domain are 
indicated, (b) HSQC spectra corresponding to four different Itk fragments: (/) Itk Pr-SH3-
SH2 (1.2mM), (zz) Itk SH3-SH2 (1.2 mM), (zzz) Itk Pr-SH3 (1.25 mM), and (zV) Itk Pr-SH3-
SH2* (P287G mutation, 1 mM). The region shown includes the indole NH of W208 and 
W209 in the Itk SH3 domain, (c) For (z'-z'v), the backbone resonance of S224 is shown for the 
Pr-SH3-SH2, SH3-SH2, Pr-SH3 and Pr-SH3-SH2* fragments, respectively, (z, z'z, iv) the 
amide backbone resonance for E269 of the SH2 domain is labeled. For both (b) and (c), the 
HSQC spectrum of the isolated Itk SH3 domain, 1.2mM (gray) is superimposed in each 
panel. The arrows indicate the extent and direction of chemical shift changes that are 
observed between SH3 alone and the larger Itk constructs. Assignment of resonances in the 
HSQC spectra of the large fragments was accomplished by comparison to previously 
assigned spectra of the isolated SH3 and SH2 domains.17,18 
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Figure 2. Chemical shift perturbation analysis of the SH3 domain residues in four different 
Itk constructs. The plotted values correspond to chemical shift differences (AS) between the 
isolated SH3 domain and the larger SH3-containing fragment (Aôx = 5sh3 - ôx, where X= 
SH3-SH2, Pr-SH3-SH2, Pr-SH3 or Pr-SH3-SH2*), (a) Itk SH3-SH2, (b) Itk Pr-SH3-SH2, (c) 
Itk Pr-SH3, and (d) Itk Pr-SH3-SH2*. AS values for l5N (open bars) and (closed bars) 
resonances are illustrated. The plus sign (+) represents residues that change in resonance 
frequency relative to the SH3 domain alone; however, the change in chemical shift or line 
broadening occurred to an extent that the resonances could no longer be unambiguously 
assigned. For the Pr-SH3-SH2 fragment in (b) the sidechain l5N resonance shift for W208 is 
greater than 1 ppm as indicated by the break in the bar. Numbering of the SH3 residues 
corresponding to full length Itk is provided in (a). Bold residues are referred to specifically 
in the text. 
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Figure 3. Three dimensional solution structure of the Itk SH3 domain17 illustrating the 
surface residues involved in binding to either the proline-rich region (a) or the SH2 domain 
(b). The well-defined ligand-binding site of the SH3 domain mediates both intramolecular 
and intermolecular interactions of the SH3 domain with the proline-rich region and the SH2 
domain, respectively, (a) Side chains highlighted in red correspond to those that exhibit a 
chemical shift change upon dimerization of both SH3-SH2 and Pr-SH3-SH2. The yellow 
residue is affected by self-association of Pr-SH3-SH2 and not the shorter SH3-SH2 fragment, 
(b) Side chains highlighted in red correspond to those that exhibit chemical shift 
perturbations upon formation of the intramolecular proline-SH3 interaction (Pr-SH3 and Pr-
SH3-SH2*). Yellow denotes side chains that exhibit chemical shift perturbations in Pr-SH3-
SH2* and not Pr-SH3. 
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Figure 4. NMR self-diffusion data for Itk Pr-SH3-SH2 (•), Itk SH3-SH2 (•) and the 
monomeric mutant Itk SH3*-SH2(W208K) (O). The data are the average values of 
normalized peak integrals obtained from four replicate experiments. Definition of variables 
and method for determination of the reported self-diffusion coefficients (Ds) was carried out 
as described previously.18 The data shown correspond to the last nine points of those shown 
in Figure 6 of reference 18, i.e., the range of the data for which the signal decay 
corresponding to the monomeric and dimeric species diverge. The error bars represent three 
times the standard deviation of the data from the individual experiments. 
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Figure 5. (a) An example of an equilibrium model for the competitive binding experiments 
shown in (b). 15N-labeled SH3 domain (circled) is mixed with unlabeled (NMR inactive) 
SH3-SH2. Two competing equilibria in fast exchange are possible: A) formation of the 
homodimer of SH3-SH2 plus unbound l5N-SH3 which will resonate at the same frequency as 
l5N-SH3 alone or B) formation of the mixed dimer of l5N-SH3 and SH3-SH2 for which 
resonance frequencies of the 15N-labeled SH3 domain reflect binding to the SH2 domain. In 
each case the species in solution that gives rise to an NMR signal is circled, (b) An overlay 
of a select region of HSQC spectra illustrating the crosspeaks corresponding to Glu228 in the 
Itk SH3 domain in the presence of three different Itk fragments. l5N-labeled Itk SH3 alone 
(1.7 mM) (/) was independently mixed with equimolar, unlabeled Itk SH2 (zz), Itk SH3-SH2 
(Hi), and Itk Pr-SH3-SH2 (z'v). (c) An overlay of a select region of HSQC spectra that 
includes the crosspeaks corresponding to Thr331 in the Itk SH2 domain in the presence of 
three different Itk fragments. l5N-labeled Itk SH2 alone (1.7 mM) (/) was independently 
mixed with equimolar, unlabeled Itk SH3(z7), Itk SH3-SH2(z7z) and Itk Pr-SH3-SH2(/v). The 
position of the crosspeak relative to isolated SH3 or SH2 domain indicates the extent to 
which the isolated domain interacts with the larger fragment. The smaller chemical shift 
differences indicate a less extensive interaction and a higher fraction of unbound, labeled 
domain. 
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Figure 6. (a) A sequence alignment generated using Clustalx33 of the CD loop within the 
SH2 domain from the five Tec kinases. An asterisk indicates the position of P287 in the Itk 
SH2 domain. Sequence accession numbers are: Itk, A47333; Btk, P35991; Rlk, A55631; 
Tec, T01380; Bmx, AAB47770.1. (b) Entire HSQC spectrum of purified, recombinant Btk 
SH2 domain, (c) (z) A select region of the l5N Itk SH3 HSQC spectrum alone (black) and in 
the presence of equimolar Itk SH2 (gray) illustrating chemical shift changes due to the Itk 
SH3/SH2 interaction. (z7) l5N Btk SH3 HSQC spectrum alone (black) and in the presence of 
equimolar Btk SH2 (gray). The region shown includes the indole NH of W251 (major form), 
W25 lm (minor form) and W252 in the Btk SH3 domain-binding pocket. (///) Same region as 
(it). I5N Btk SH3 HSQC spectrum alone (black) and in the presence of equimolar Itk SH2 
domain (gray). No chemical shift perturbations are observed for the Btk titrations. 
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Figure 7. (a) Model of the Itk Pr-SH3-SH2 dimer. Intermolecular interaction between the Itk 
SH3 and SH2 domains requires the cis conformation of the imide bond preceding P287. (b) 
Mutation of P287 to glycine eliminates the possibility that the 286-287 amide bond can adopt 
the cis conformation and results in formation of the intramolecular proline-SH3 interaction. 
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CHAPTER 5. GENERAL SUMMARY AND CONCLUSIONS 
This dissertation provides insight into role of the SH3 and SH2 domains of 
interleukin-2 tyrosine kinase (Itk) in regulating protein-protein interactions and catalytic 
activity, thereby extending the understanding of these domains in mediating protein-tyrosine 
kinase function. A proline cis/trans isomerization event has been identified in the Itk SH2 
domain using nuclear magnetic resonance spectroscopy (NMR) (1). This slow exchange 
event causes the SH2 domain to adopt two distinct conformations in solution, a trans 
proline-containing conformer and a cis proline-containing conformer. Larger fragments of Itk, 
e.g. SH3SH2 and PrSH3SH2, preserve this conformational heterogeneity (2, 3). Likewise, in 
vitro ligand binding assays reveal the presence of both the cis and trans conformers in full 
length Itk (1). The trans confomer appears to be two times more populated than the cis 
conformer in small fragments of Itk; however, in the context of full length Itk, this ratio may 
be different. 
The cis and trans conformers display distinct ligand binding specificities (I). The 
canonical phosphotyrosine-containing SH2 ligand, through the well-characterized SH2 
domain ligand binding surface, preferentially binds the trans conformer. In contrast, the Itk 
SH3 domain, a novel ligand binding partner, preferentially binds to the cis conformer. The 
SH3-SH2 interaction is dependent upon the conformational^ heterogenous proline residue in 
the Itk SH2 domain, and reveals a newly defined ligand binding surface on the Itk SH2 domain 
(2). The SH3-SH2 interaction surface encompasses four main loops in the SH2 domain, the 
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AB, BG, EF and CD loops; the EF and BG loops also form part of the phosphotyrosine 
specificity pocket. The SH3-SH2 interaction surface maps out to the canonical ligand binding 
pocket on the SH3 domain, known to bind proline-rich sequences containing the PXXP 
motif. However, a PXXP motif is not found within the region of the SH2 domain involved in 
the SH3-SH2 interaction, nor is a phosphotyrosine-containing (pTyr) sequence present 
within the SH3 domain. Thus, the SH3-SH2 interaction reveals novel ligand binding 
capacities of both domains. 
The Itk SH3 and SH2 domains were not able to bind SH2 and SH3 domains from 
other proteins; therefore, the Itk SH3-SH2 interaction appears to be specific (2, 3). In 
addition, the Itk SH2 domain did not interact with the SH3 domain of the closely related Tec 
family kinase Btk. This result provides evidence that Tec family kinase members may differ 
significantly on a structural level. The unique ligand specificity of the Itk SH3 and SH2 
domains may be necessary to regulate explicit interactions with other proteins, although it 
remains to be determined if Itk is capable of interacting with other signaling partners through 
an SH3-SH2 interaction. 
The Itk SH3SH2 dual domain-containing fragment and the larger PrSH3SH2 fragment 
self-associate in solution through the SH3-SH2 intermolecular interaction (2, 3). 
Dimerization of the SH3SH2 and PrSH3SH2 fragments limits the accessibility of the SH2 
domain to ligands, e.g. single Itk SH3 domain and pTyr peptide, and the SH3 domain to 
ligands, e.g. single Itk SH2 domain and polyproline peptide, based on binding competition 
experiments. The SH3 and SH2 domain ligand binding sites appear to become less accessible 
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as the Itk fragments become increasingly larger, suggesting that full-length Itk may have a 
propensity to dimerize. It is therefore possible that Itk dimerization in vivo is involved in 
regulating Itk activity. Membrane localization of Itk in response to antigen receptor 
stimulation may increase the local concentration of Itk, resulting in Itk dimerization. 
Although the activation state of the putative Itk dimer remains unknown, it may be required 
for SH3 domain autophosphorylation in trans, which leads to Itk activation (4-6). 
Alternatively, dimerization may be a means of controlling Itk function by hindering the 
accessibility of the regulatory domains, thereby preventing interactions with other signaling 
molecules, providing a plausible mechanism for both activation and inactivation. 
The Itk SH3-SH2 mediated self-association is in contrast to the mechanism of self-
association for the other Tec family kinases (7-9). Btk and Tec have been shown to dimerize 
via an intermolecular proline-SH3 domain interaction. In fact, the Btk SH3 domain did not 
appear to have any affinity for its own SH2 domain (3). Perhaps the different mechanisms of 
self-association suggest that the Itk SH2 domain may play a principal role in regulating the 
function of Itk compared to the role of the SH2 domains in the other Tec family kinases. 
Regardless of the mode of self-association, all of the Tec family members studied to date 
appear to dimerize, and dimerization may be a means of regulating catalytic activity within 
the Tec family. Thus, further assessment of the effects of dimerization on all the Tec family 
kinases is necessary before one can determine the importance of self-association. 
In addition to mediating the Itk SH3-SH2 interaction, the conformational^ 
heterogenous proline residue is required for the recognition of the Itk SH2 as a substrate for 
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the peptidyl-prolyl isomerase (PPIase) cyclophilin A (1). Cyclophilin A (CyP A) appears 
to increase the exchange rate between the cis and trans proline conformers at 
substoichiometric concentrations as determined by NMR. The acceleration in the exchange 
rate appears to be specific for CyP A since there was no evidence of an increase in the 
exchange rate between the conformers in the presence of the PPIase FK-506 binding protein 
(FKBP). 
CyP A appears to be an inhibitor of Itk catalytic activity in vitro ( 1 ). The level of Itk 
autophosphorylation was significantly lower in the presence of CyP A, as measured using an 
in vitro kinase assay. The inhibitory effect of CyP A on Itk autophosphorylation levels was 
diminished when CyP A was pretreated with the cyclophilin inhibitor cyclosporin A (CsA) 
prior to the in vitro kinase assay. 
CyP A also seems to regulate Itk phosphorylation levels in Jurkat T cells (1). Itk 
phosphorylation levels were higher after anti-CD3 stimulation in Jurkat cells pretreated with 
CsA than in untreated cells. In other words, CsA acts to activate Itk, likely through 
inhibiting the catalytic site of Cyp A, which prevents Cyp A inhibition of Itk. In addition, 
Itk phosphorylation levels decreased with increasing amounts of co-immunoprecipitated CyP 
A. Thus, providing further evidence that CsA treatment led to increases in Itk 
phosphorylation by alleviating CyP A inhibition of Itk. Consistent with this analysis was 
the observation that following anti-CD3 stimulation, increases in the phosphorylation levels 
of the downstream signaling partner of Itk, phospholipase Cyl (PLC yl), paralleled increases 
in Itk phosphorylation levels in cells pretreated with CsA. In contrast, the phosphorylation 
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levels after anti-CD3 stimulation of the 70 kD zeta chain associated protein (Zap 70), an 
upstream signaling partner of Itk, did not increase with CsA pretreatment compared to 
untreated cells. Similar to the specificity observed by NMR, Itk phosphorylation levels 
remained unaffected after anti-CD3 stimulation in cells pretreated with the inhibitor of 
FKBP, FK-506, compared to untreated cells. 
The effect of CyP A on Itk phosphorylation in Jurkat T cells appears to be mediated 
by the conformational^ heterogenous Itk SH2 domain (I). Competitive binding experiments 
with ligands that target the SH2 domain were able to disrupt CyP A co-immunoprecipitation. 
Thus, the Itk-CyP A interaction will likely disrupt Itk SH3-SH2 mediated dimerization, and 
may stabilize a down-regulated, monomeric form of Itk. The conformational state of CyP A 
bound Itk has not been determined, although one can speculate that when the SH2 domain is 
unavailable for dimerization the intramolecular proline-SH3 domain interaction, which is 
prevented in larger fragments of Itk as a result of self-association, may occur (2, 3, 10). 
Analogous to CyP A bound Itk, it was observed that the proline-rich region could bind 
intramolecularly to a mutant PrSH3SH2(P287G) fragment in which the conformational^ 
hetergenous proline was mutated to a glycine, and the protein therefore was unable to self-
associate (3). Consequently, both the SH3 and SH2 domain ligand binding sites may be 
unavailable in CyP A bound Itk, providing a possible mechanism for Itk regulation. 
Currently, the precise mechanism of CyP A regulation of Itk activity remains unclear. 
CyP A may be acting as a catalyst to increase the rate of cis/trans isomerization, allowing 
more rapid responses to ligand binding events, or may be acting as a stable binding partner, 
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occluding ligand binding sites. T cell receptor signaling events occur within seconds of 
contact with an antigen-receptor presenting cell, leading to rapid increases in intracellular 
protein phosphorylation levels (11-13). CyP A, as a catalyst, may be necessary to accelerate 
Itk cis/trans isomerization in order for Itk to respond rapidly to antigen receptor stimulation. 
CyP A, as a binding partner, may regulate ligand binding interactions to both the SH3 and 
SH2 domains, as well as inhibit Itk catalytic activity. Nevertheless, the identification of the 
Itk-CyP A interaction provides the first example of CyP A in regulating the catalytic activity 
of a non-receptor tyrosine kinase. Not only does this allow us to propose a new mode of 
kinase regulation but also provides a cellular role for CyP A in mediating T cell signaling 
events. In broader terms, identification of the Itk SH2 domain as a substrate for CyP A 
bestows the opportunity to study the mechanistic details of a PPIase on a folded protein 
substrate in solution. 
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